<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T18:01:56Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4963112" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4963112</identifier>
        <datestamp>2016-08-08</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4963112</article-id>
              <article-id pub-id-type="pmcid">PMC4963112</article-id>
              <article-id pub-id-type="pmc-uid">4963112</article-id>
              <article-id pub-id-type="pmid">27463808</article-id>
              <article-id pub-id-type="pmid">27463808</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0160034</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-16-13972</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Nucleic acids</subject>
                      <subj-group>
                        <subject>RNA</subject>
                        <subj-group>
                          <subject>Messenger RNA</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Cell Biology</subject>
                    <subj-group>
                      <subject>Cellular Types</subject>
                      <subj-group>
                        <subject>Animal Cells</subject>
                        <subj-group>
                          <subject>Connective Tissue Cells</subject>
                          <subj-group>
                            <subject>Osteoblasts</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Biological Tissue</subject>
                      <subj-group>
                        <subject>Connective Tissue</subject>
                        <subj-group>
                          <subject>Connective Tissue Cells</subject>
                          <subj-group>
                            <subject>Osteoblasts</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Biological Tissue</subject>
                      <subj-group>
                        <subject>Connective Tissue</subject>
                        <subj-group>
                          <subject>Connective Tissue Cells</subject>
                          <subj-group>
                            <subject>Osteoblasts</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Physics</subject>
                    <subj-group>
                      <subject>Gravitation</subject>
                      <subj-group>
                        <subject>Artificial Gravity</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>Extracellular Matrix Proteins</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Cell Biology</subject>
                    <subj-group>
                      <subject>Cell Processes</subject>
                      <subj-group>
                        <subject>Cell Death</subject>
                        <subj-group>
                          <subject>Apoptosis</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>DNA-binding proteins</subject>
                        <subj-group>
                          <subject>Histones</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Hormones</subject>
                      <subj-group>
                        <subject>Peptide Hormones</subject>
                        <subj-group>
                          <subject>Prolactin</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Metabolism</subject>
                      <subj-group>
                        <subject>Bone and Mineral Metabolism</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The Role of Parathyroid Hormone-Related Protein (PTHrP) in Osteoblast Response to Microgravity: Mechanistic Implications for Osteoporosis Development</article-title>
                <alt-title alt-title-type="running-head">PTHrP and Microgravity</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Camirand</surname>
                    <given-names>Anne</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Goltzman</surname>
                    <given-names>David</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gupta</surname>
                    <given-names>Ajay</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kaouass</surname>
                    <given-names>Mohammadi</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Panda</surname>
                    <given-names>Dibyendu</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Karaplis</surname>
                    <given-names>Andrew</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>McGill University Health Centre, Montréal, Québec, Canada</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Oncology, McGill University, Montreal, Québec, Canada</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Biology, Université Sainte-Anne, Pointe-de-l’Eglise, Nova Scotia, Canada</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Heymann</surname>
                    <given-names>Dominique</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Faculté de médecine de Nantes, FRANCE</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <fn fn-type="con" id="contrib001">
                  <p>Conceived and designed the experiments: AK AC DG AG. Performed the experiments: AC MK DP. Analyzed the data: AC. Wrote the paper: AC.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>david.goltzman@mcgill.ca</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>7</month>
                <year>2016</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2016</year>
              </pub-date>
              <volume>11</volume>
              <issue>7</issue>
              <elocation-id>e0160034</elocation-id>
              <history>
                <date date-type="received">
                  <day>6</day>
                  <month>4</month>
                  <year>2016</year>
                </date>
                <date date-type="accepted">
                  <day>12</day>
                  <month>7</month>
                  <year>2016</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2016 Camirand et al</copyright-statement>
                <copyright-year>2016</copyright-year>
                <copyright-holder>Camirand et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0160034.pdf"/>
              <abstract>
                <p>Prolonged skeletal unloading through bedrest results in bone loss similar to that observed in elderly osteoporotic patients, but with an accelerated timeframe. This rapid effect on weight-bearing bones is also observed in astronauts who can lose up to 2% of their bone mass per month spent in Space. Despite the important implications for Spaceflight travelers and bedridden patients, the exact mechanisms involved in disuse osteoporosis have not been elucidated. Parathyroid hormone-related protein (PTHrP) regulates many physiological processes including skeletal development, and has been proposed as a mechanosensor. To investigate the role of PTHrP in microgravity-induced bone loss, trabecular and calvarial osteoblasts (TOs and COs) from <italic>Pthrp</italic>
<sup>+/+</sup> and <sup>-/-</sup> mice were subjected to actual Spaceflight for 6 days (Foton M3 satellite). <italic>Pthrp</italic>
<sup>+/+</sup>, <sup>+/-</sup> and <sup>-/-</sup> osteoblasts were also exposed to simulated microgravity for periods varying from 6 days to 6 weeks. While COs displayed little change in viability in 0<italic>g</italic>, viability of all TOs rapidly decreased in inverse proportion to PTHrP expression levels. Furthermore, <italic>Pthrp</italic><sup>+/+</sup> TOs displayed a sharp viability decline after 2 weeks at 0<italic>g</italic>. Microarray analysis of <italic>Pthrp</italic><sup>+/+</sup> TOs after 6 days in simulated 0<italic>g</italic> revealed expression changes in genes encoding prolactins, apoptosis/survival molecules, bone metabolism and extra-cellular matrix composition proteins, chemokines, insulin-like growth factor family members and Wnt-related signalling molecules. 88% of 0<italic>g</italic>-induced expression changes in <italic>Pthrp</italic><sup><italic>+/+</italic></sup> cells overlapped those caused by <italic>Pthrp</italic> ablation in normal gravity, and pulsatile treatment with PTHrP<sub>1-36</sub> not only reversed a large proportion of 0<italic>g</italic>-induced effects in <italic>Pthrp</italic><sup><italic>+/+</italic></sup> TOs but maintained viability over 6-week exposure to microgravity. Our results confirm PTHrP efficacy as an anabolic agent to prevent microgravity-induced cell death in TOs.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000016</institution-id>
                      <institution>Canadian Space Agency</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>9F-007-05-1657</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Karaplis</surname>
                      <given-names>Andrew</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This work was completed through the Canadian Space Agency (CSA) E/Osteo program contract # 9F-007-05-1657. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="4"/>
                <page-count count="31"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Microarray data was deposited in the NCBI GEO database and is available under accession number GSE 78980. All other relevant data are within the paper and its Supporting Information files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Microarray data was deposited in the NCBI GEO database and is available under accession number GSE 78980. All other relevant data are within the paper and its Supporting Information files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Bone loss due to osteoporosis (OP) is the most common cause of fractures among the elderly. Age-related OP elicits fractures with minimal trauma in up to 40% of women and 20% of men over the age of fifty and is a major health and fiscal burden [<xref rid="pone.0160034.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0160034.ref002" ref-type="bibr">2</xref>]. OP can also develop in younger individuals as a consequence of premature menopause or skeletal unloading. In the absence of gravity load on weight-bearing bones, the equilibrium between osteoblastic bone formation and osteoclastic bone resorption is uncoupled and the balance is shifted towards resorption, resulting in bone loss. Skeletal disuse can occur after prolonged bedrest on Earth but is also encountered in the weightless conditions of Space [<xref rid="pone.0160034.ref003" ref-type="bibr">3</xref>]. During orbital flight, astronauts are exposed to gravity forces below the physiological detection threshold (≤ 10<sup>-5</sup><italic>g</italic>). Even a short-duration exposure to microgravity results in profound metabolic changes, and the lack of mechanical loading causes rapid demineralization in bones of the lower body leading to development of a disuse osteoporotic-like phenotype [<xref rid="pone.0160034.ref004" ref-type="bibr">4</xref>]. Microgravity can cause a remarkable loss of up to 2% of load-bearing bone mineral density (BMD) per month spent in Space, compared to an average 1% per year observed on Earth (starting from approximately 24–30 years of age when peak bone mass is attained) [<xref rid="pone.0160034.ref005" ref-type="bibr">5</xref>]. Microgravity-induced bone loss shows no sign of stabilization while at 0<italic>g</italic> and displays a highly-variable speed of skeletal recovery upon return to Earth [<xref rid="pone.0160034.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0160034.ref010" ref-type="bibr">10</xref>]. The causes of this rapidly-progressing syndrome have not been elucidated, and only partially-effective countermeasures have been developed [<xref rid="pone.0160034.ref011" ref-type="bibr">11</xref>].</p>
              <p>Skeletal loss has severe implications for long-time inhabitants of the International Space Station and will be a hindrance to spatial exploration since up to one half of bone mass could be lost during a three-year trip to Mars, resulting in mission-compromising fractures as well as complications from renal stones caused by skeleton-released calcium [<xref rid="pone.0160034.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0160034.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0160034.ref014" ref-type="bibr">14</xref>]. The mechanosensors which control bone loss during unloading are not known, and the striking difference in microgravity-induced mineral loss between bone derived from endochondral formation (eg. trabecular bone) and bone derived from membraneous formation (calvarial bone) has also not been fully analysed. Elucidation of the causes of skeletal loss at 0<italic>g</italic> is further complicated by the fact that the two main cellular components regulating bone turnover, the osteoblasts and osteoclasts, are differently affected by microgravity. Osteoblasts exposed to 0<italic>g</italic> undergo decreases in cellular integrity with modified microtubule structure, focal adhesions and increasingly fragmented nuclei, while osteoclasts present higher numbers of discrete resorption pits and increased cellular activity [<xref rid="pone.0160034.ref015" ref-type="bibr">15</xref>]. Spaceflight countermeasures to bone loss include exercise and resistive training, artificial musculoskeletal loading, electrical stimulation and vibration treatment, as well as dietary additions of vitamin D, K, calcium and various drugs [<xref rid="pone.0160034.ref016" ref-type="bibr">16</xref>]. While physical activity in Space helps to counter muscle atrophy, it does not prevent bone loss and none of these measures fully compensate for skeletal degradation [<xref rid="pone.0160034.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0160034.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0160034.ref014" ref-type="bibr">14</xref>]. In long-duration bedrest studies which mimic microgravity’s physiological effects, treatment of male subjects with the anti-resorptive bisphosphonate drugs alendronate or pamidronate (osteoclast inhibitors) prevented some, but not all, bone loss [<xref rid="pone.0160034.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0160034.ref018" ref-type="bibr">18</xref>]. Furthermore, skeletal bone formed during bisphosphonate administration does not display the mechanical integrity of normal bone [<xref rid="pone.0160034.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0160034.ref019" ref-type="bibr">19</xref>] and high doses of anti-resorptive drugs may inhibit formation in unloaded bone [<xref rid="pone.0160034.ref020" ref-type="bibr">20</xref>]. Consequently, an alternative to be investigated is the use of anabolic substances such as parathyroid hormone (PTH) and parathyroid hormone-related hormone (PTHrP) which promote bone formation rather than inhibit resorption [<xref rid="pone.0160034.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0160034.ref022" ref-type="bibr">22</xref>].</p>
              <p>PTHrP is a secreted factor expressed in almost all normal fetal and adult tissues. It acts as an autocrine, paracrine or intracrine factor in a wide range of developmental and physiological processes, including skeletal development and growth [<xref rid="pone.0160034.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0160034.ref024" ref-type="bibr">24</xref>]. The 13 N-terminal amino acids of PTHrP are highly-homologous to those of PTH, a characteristic that allows PTHrP to activate their common type 1 PTH/PTHrP receptor. PTH and PTHrP differ in the remainder of their sequence, a fact which accounts at least in part for the distinct properties of the two molecules [<xref rid="pone.0160034.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0160034.ref024" ref-type="bibr">24</xref>]. The major role played by PTHrP in bone development was made evident through <italic>Pthrp</italic> gene deletion which caused profound abnormalities in the development of the cartilaginous growth plate [<xref rid="pone.0160034.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0160034.ref026" ref-type="bibr">26</xref>], a phenotype not seen in mice with <italic>PTH</italic> deletion [<xref rid="pone.0160034.ref027" ref-type="bibr">27</xref>]. Heterozygous mice with only one null <italic>Pthrp</italic> allele (<italic>Pthrp</italic>
<sup><italic>+/-</italic></sup>) developed premature OP due to decreased bone formation linked to enhanced apoptosis of osteogenic cells [<xref rid="pone.0160034.ref028" ref-type="bibr">28</xref>]. Knock-out mice with a selective <italic>Pthrp</italic> deletion targeting only the osteoblasts further recapitulated this severe osteoporotic phenotype and importantly, exogenous application of PTH or PTHrP prevented apoptosis and associated bone loss [<xref rid="pone.0160034.ref029" ref-type="bibr">29</xref>]. PTH<sub>1-34</sub> (teriparatide, Forteo<sup>™</sup>) is currently the only approved anabolic drug for treatment of osteoporosis but may cause bone resorption, hypercalcemia, nausea, muscle cramps and other adverse side-effects. In contrast, a study conducted on post-menopausal women showed that the <sub>1–36</sub> N-terminal peptide of PTHrP did not activate bone resorption (based on bone marker responses, although changes in BMD were not measured) and acted as a pure anabolic agent while causing none of the adverse effects observed with teriparatide [<xref rid="pone.0160034.ref030" ref-type="bibr">30</xref>]. Although intermittent treatment with PTHrP causes an anabolic response, continuous treatment causes paradoxical downregulation of osteogenic genes resulting in skeletal catabolism [<xref rid="pone.0160034.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0160034.ref032" ref-type="bibr">32</xref>].</p>
              <p>Decreased expression levels of PTHrP have been reported in rat long bones and cultured osteoblasts following exposure to microgravity [<xref rid="pone.0160034.ref033" ref-type="bibr">33</xref>], and loss of PTHrP may underlie at least part of the pathophysiology of microgravity-induced OP. We consequently tested the hypothesis that PTHrP could counter actual or simulated microgravity-induced deleterious effects in osteoblasts, and we investigated a timeline of viability for osteoblasts in weightlessness which would predispose astronauts to impaired bone formation. We also examined the efficacy of exogenous PTHrP<sub>1-36</sub> peptide administration in preventing osteoblast viability loss in microgravity conditions. For these studies, we used trabecular and calvarial osteoblasts isolated one day before birth from bones of <italic>Pthrp</italic>
<sup>+/+</sup>, <sup>+/-</sup>, or <sup>-/-</sup> mice. The cells in adherent conditions were subjected to Spaceflight aboard the Foton M3 satellite or to simulated microgravity in a Synthecon rotary cell culture system (RCCS) for 6-day experiments, with or without intermittent PTHrP <sub>1–36</sub> treatment. We observed that PTHrP expression confers resistance to microgravity-induced cell death, that a very large proportion of the genes affected by microgravity is common to those affected by <italic>Pthrp</italic> gene deletion, and that intermittent treatment with the PTHrP<sub>1-36</sub> peptide reverses the 0<italic>g</italic> effects on TO viability.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and Methods</title>
              <sec id="sec003">
                <title>Animal Ethics Statement</title>
                <p>All experiments were carried out in compliance with regulations of the McGill University Institutional Animal Care Committee (Animal permit: 5210) which specifically approved this study.</p>
                <p>The mice were housed in conventional (non-barrier) animal facilities at 21°C with light-dark cycles of 12 hours, and were fed Bacon Softies<sup>™</sup> soft pellets (Bio Serv) and water from drinking bottles <italic>ad libitum</italic>.</p>
              </sec>
              <sec id="sec004">
                <title>Animals</title>
                <p>Mice with various levels of <italic>Pthrp</italic> gene ablation (wild-type <italic>Pthrp</italic>
<sup>+/+</sup>, heterozygous <italic>Pthrp</italic>
<sup>+/-</sup>, and homozygous <italic>Pthrp</italic>
<sup>-/-</sup>) in a C57BL/6 background [<xref rid="pone.0160034.ref026" ref-type="bibr">26</xref>] were used to obtain osteoblasts. Because homozygous animals (<italic>Pthrp</italic>
<sup>-/-</sup>) exhibit perinatal lethality due to skeletal and pulmonary problems [<xref rid="pone.0160034.ref026" ref-type="bibr">26</xref>], osteoblasts were collected from fetal mice of all types one day before birth. Briefly, <italic>Pthrp</italic>
<sup>+/-</sup> males were bred with <italic>Pthrp</italic>
<sup>+/-</sup> females, pregnant females were sacrificed by cervical dislocation one day before partum and the fetal mice collected and sacrificed by decapitation. The animals were immediately surface-sterilized in 70% ethanol, tail samples were preserved for genotyping, and femoral and cranium bones extracted immediately to obtain trabecular and calvarial osteoblast cells respectively.</p>
              </sec>
              <sec id="sec005">
                <title>Preparation of osteoblasts and cell culture</title>
                <p>The trabecular and calvarial cells were obtained by a method modified after [<xref rid="pone.0160034.ref034" ref-type="bibr">34</xref>]. Briefly, calvarial (cranium, derived from membraneous bone formation) and trabecular (femur, derived from endochondral bone formation) bones were dissected from the animals and predigested in 6-well culture plates for 15 min at 37°C with gentle rotation in digestion medium (TCDA) made immediately before use: trypsin 0.05%, type I collagenase (2 mg/ml, Gibco), DNAse I (0.3 mg/ml, Sigma), penicillin streptomycin (100 U/ml). Bones were transferred to new 6-well plates with fresh TCDA, chopped into small slivers, particles were transferred to a third plate with TCDA and incubated at 37°C 15 min with rotation. Finally, the bone fragments were transferred to a fourth plate containing MAF medium (α-MEM with 15% FBS, penicillin/streptomycin 100 U/ml, fungizone 0.25 ug/ml) and incubated without rotation at 37°C in a humidified cell incubator (5% CO<sub>2</sub>). Only the cells emerging from the bone fragments at this step were kept for experimental purposes. The MAF medium was changed every two days and cells were transferred to 6-well plates when confluent. Aliquots were incubated with AGD differenciation medium (α-MEM 15% FBS, penicillin/streptomycin 100U/ml, fungizone 0.25 ug/ml, ascorbic acid 50 ug/ml, glycerophosphate 10 mM and dexamethasone 0,1 uM final) [<xref rid="pone.0160034.ref035" ref-type="bibr">35</xref>] or MAF as control to test for differenciation markers. The osteoblast primary cultures were filtered through sterile nylon cell strainers (100 microns, BD Biosciences), passaged twice, and 500,000 cells (minimum) were frozen per vial in 90% FBS, 10% DMSO using cryojars (ethanol/ dry ice) for 4 hours at -80°C. The cell vials were transferred to liquid nitrogen storage after 2 days. All culture reagents were from Wisent.</p>
              </sec>
              <sec id="sec006">
                <title>Genotyping</title>
                <p>Tail segments were incubated in lysis buffer (100 mM Tris-HCl 8.0, 5 mM EDTA 8.0, 0.2% SDS, 200 mM NaCl, 0.2 mg/ml proteinase K) at 55°C for 16 hours. Genomic DNA was extracted with phenol/CHCl<sub>3</sub>, ethanol-precipitated and resuspended in TE buffer. Aliquots were digested with PvuII, separated by agarose electrophoresis, and blots hybridized with a PTHrP-specific probe [<xref rid="pone.0160034.ref026" ref-type="bibr">26</xref>].</p>
              </sec>
              <sec id="sec007">
                <title>Culture for Space mission bioreactors</title>
                <p>The available surface on culture slides in the Foton M3 mission biomodules was extremely limited, and allowed testing of the <italic>Pthrp</italic>
<sup>+/+</sup> and <sup>-/-</sup> genotypes only. Cultured primary osteoblasts of both genotypes from calvarial and trabecular origin were exposed to AGD differenciation medium for 4–5 days then trypsinised, counted and cells were attached at very high density (25,000 cells/cm<sup>2</sup>, or 6,500 cells/compartment in 4-compartment slides) to the growth surfaces of sterile CC2 glass slides (Nunc). These slides were handled in a completely sterile fashion and placed inside 10cm culture dishes in a normal culture incubator (5% CO<sub>2</sub>) for a 4-day pre-attachment period in AGD medium. The CC2 slides superstructures were removed under sterile conditions, the glass slides inserted into the sterile mission biomodules and connected to the feeding syringes and waste exhaust lines of the automated experimental trays (<xref ref-type="fig" rid="pone.0160034.g001">Fig 1A</xref>, CALM Technologies, Kingston, Canada). Two identical trays were sealed and powered by battery to maintain 37°C temperature and provide medium changes every 48 hours. One tray was kept at 1<italic>g</italic> at the European Space Research and Technology Centre (ESTEC, Noordwijk, The Netherlands) while the twin tray (for 0<italic>g</italic>) was transported over a period of 4 days to Baikonour and installed aboard the Roscosmos (Russian Federal Space Agency) Foton M3 satellite which was launched into orbital flight. (<ext-link ext-link-type="uri" xlink:href="http://esamultimedia.esa.int/docs/foton/FOTON-M3_brochure.pdf">http://esamultimedia.esa.int/docs/foton/FOTON-M3_brochure.pdf</ext-link>).</p>
                <fig id="pone.0160034.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Endogenous PTHrP protects trabecular osteoblasts from Space microgravity-induced apoptosis. (6-day experiments).</title>
                    <p><bold>(A)</bold> Automated flight-ready tray for conducting cell culture experiments aboard Foton M3 satellite. Osteoblasts were attached onto CC2 culture slides inside three bioreactors (lower right) in a sealed pathway. <bold>(B)</bold> Proportion of apoptotic cells in trabecular osteoblasts in bioreactors after 6 days in Space microgravity (0<italic>g</italic>) or in normal Earth gravity (1<italic>g</italic>). ** p &lt; 0.01. White bars: untreated; black bars: 2-h daily treatment with PTHrP<sub>1-36</sub> 10<sup>-8</sup>M. <bold>(C)</bold> Proportion of apoptotic cells in calvarial osteoblasts in bioreactors after 6 days in Space microgravity (0<italic>g</italic>) or in normal Earth gravity (1<italic>g</italic>). No PTHrP<sub>1-36</sub> treatment was conducted on calvarial cells. Scale bar A: 15 cm.</p>
                  </caption>
                  <graphic xlink:href="pone.0160034.g001"/>
                </fig>
              </sec>
              <sec id="sec008">
                <title>Experimental flight conditions</title>
                <p>Experimental conditions were automatically started one day after reaching orbital flight. Cells were fed fresh AGD growth medium every day, or received a daily 2-hour treatment with 10<sup>-8</sup>M PTHrP peptide amino acids 1–36, (Bachem, Germany) in AGD, followed by a phosphate-buffered saline (PBS) rinse, then fresh AGD medium. Intermittent PTHrP<sub>1-36</sub> treatment was used as it provides anabolic effects on bone whereas continuous treatment does not [<xref rid="pone.0160034.ref036" ref-type="bibr">36</xref>]. After 6 days of experimentation, the cells were fixed with 1% glutaraldehyde <italic>in situ</italic> on the slides within the 3 bioreactors, then stored in PBS at 15°C. After retrieval from the satellite, slides were stored in PBS at 4°C until assays. Experimental conditions were identical for both 0<italic>g</italic> and 1<italic>g</italic> trays (described in <xref ref-type="supplementary-material" rid="pone.0160034.s002">S1 Table</xref>).</p>
              </sec>
              <sec id="sec009">
                <title>Apoptosis assay</title>
                <p>Mission slides were analysed for apoptosis events using the single-stranded DNA (ssDNA) detection technique [<xref rid="pone.0160034.ref037" ref-type="bibr">37</xref>]. The glass slides with glutaraldehyde-fixed cells were heated for 20 minutes at 75°C in neat formamide, rinsed with H<sub>2</sub>O, blocked with 3% non-fat dry milk for 1h at room temperature, reacted with a monoclonal antibody to ssDNA (1:10) coupled with horseradish peroxidase (Chemicon), then colored with freshly-prepared diaminobenzidine (DAB) and counter-stained with hematoxylin. Fixed cells positive for DAB (i.e.ssDNA) were apoptotic at the time of in-flight fixation, cells stained with hematoxylin were viable at the same moment. 11 optical fields were counted on each slide and the proportion of apoptotic cells to non-apoptotic cells at the time of fixation was determined.</p>
              </sec>
              <sec id="sec010">
                <title>Simulated microgravity in rotary cell culture system</title>
                <p>The flight data was completed, confirmed and expanded using the Synthecon Revolving Cell Culture System (RCCS) Earth-based microgravity simulator consisting of a horizontally-rotating axis connected to a sterile 10-ml disposable growth chamber called High Aspect Ratio Vessel (HARV) with a CO<sub>2</sub>-permeable membrane (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2A</xref>, Synthecon, Houston, TX). The equipment was used inside a standard CO<sub>2</sub> incubator while connected to an external speed regulator and power supply. Because free, non-adherent cells would rapidly undergo anoikis-induced apoptosis [<xref rid="pone.0160034.ref038" ref-type="bibr">38</xref>], osteoblasts grown in AGD medium were trypsinised, counted, and aliquots of 10<sup>6</sup> cells were pre-attached to sterile MicroHex microcarriers (Nunc) using 1 ml of 50 cm<sup>2</sup>/ml MicroHex per 10<sup>6</sup> cells, and incubated 4 days in AGD medium at 30°C in culture plates coated with sterile 4% agarose (Gibco) to prevent attachment [<xref rid="pone.0160034.ref039" ref-type="bibr">39</xref>]. The medium was changed every second day. Primary osteoblasts attach to the surface of the microcarriers and develop in a manner similar to osteoblasts plated on standard culture plasticware except for the fact that the cells create three-dimensional connections with more than one plastic surface, resulting in microcarrier-cell aggregates (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2B and 2C</xref>). Within 24 hours of attachment at 1<italic>g</italic>, the cell/microcarrier structures assembled into clumps visible to the naked eye which mimicked the more natural cellular environment found in a living organism. After 5 days, MicroHex-attached osteoblasts (5 x 10<sup>6</sup>) were transferred to 10-ml sterile Synthecon HARV chambers containing AGD medium which were placed inside a standard cell incubator (37°C, 5% CO<sub>2</sub>). The units were rotated at optimized speed (20 rpm) to maintain the constant free fall state characteristic of orbital flight and which is the cause of weightlessness. The rotation simulated 0<italic>g</italic> while avoiding shear forces due to excessive rotation and collision with vessel walls. Two chambers were rotated simultaneously on the same rotation axis, one containing the untreated control receiving daily medium change, the other receiving a daily 2-h PTHrP<sub>1-36</sub> 10<sup>-8</sup>M treatment followed by fresh medium. Cells on microcarriers but growing in AGD medium in agarose-coated plasticware in a standard cell culture incubator were used as 1g controls and received the same regimen of treatments or medium changes. Triplicate experiments were conducted with conditions identical to those aboard the satellite. At the end of the 6<sup>th</sup> day, cells were collected, trypsinized to release them from the microcarriers, and aliquots analysed for viability by Trypan Blue analysis. Treatment and media change conditions for 6-week experiments were identical to those lasting 6 days.</p>
                <fig id="pone.0160034.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Allelic effect of endogenous PTHrP levels in simulated microgravity, and compensation by exogenous PTHrP <sub>1–36</sub> (6-day experiments).</title>
                    <p><bold>(A)</bold> Microgravity simulation apparatus (RCCS) with one rotating culture unit (HARV). <bold>(B)</bold> MicroHex carriers with attached trabecular osteoblasts in culture. <bold>(C)</bold> Cell-induced MicroHex aggregate in culture (occurs for both trabecular and calvarial osteoblasts). <bold>(D)</bold> Trabecular osteoblast viability after 6 days on MicroHex carriers in normal gravity (1<italic>g</italic>) or in simulated microgravity (0<italic>g</italic>) (triplicate 6-day experiments). White bars: untreated; black bars: 2-h daily treatment with PTHrP<sub>1-36</sub> 10<sup>-8</sup>M. ** p &lt; 0.01, *** p &lt; 0.001. Scale bars: B, C: 200 μm.</p>
                  </caption>
                  <graphic xlink:href="pone.0160034.g002"/>
                </fig>
              </sec>
              <sec id="sec011">
                <title>Trypan Blue viability test</title>
                <p>During long-term experiments, sampling from the HARV rotating chamber was conducted at weekly intervals. Aliquots of cell-microcarriers aggregate were quickly collected in sterile fashion from the momentarily-immobilised HARV, and transferred to sterile microfuge tubes. The aggregates were washed with growth medium then trypsinized in tubes kept horizontally for 20 minutes at 37°C. After cell detachment, the tubes were put vertically in racks to sediment the microcarriers, and the supernatant collected. Microcarriers were rinsed twice with growth medium to collect residual cells, the trypsinised combined volumes were centrifuged, the cells resuspended in growth medium and stained with Trypan Blue for viability [<xref rid="pone.0160034.ref040" ref-type="bibr">40</xref>].</p>
              </sec>
              <sec id="sec012">
                <title>RNA extraction and microarrays</title>
                <p>Collected cells from duplicate experiments were lysed on MicroHex microcarriers using Trizol (InVitrogen, Carlsbad, CA) according to manufacturer’s intructions, frozen at -80°C and sent for RNA extraction and microarray analysis to the Centre d’Innovation de Génome Québec, (Montréal, QC). Illumina Mouse Ref-8 v2.0 slides (25,697 probes) were hybridized with trabecular osteoblast samples (<italic>Pthrp</italic>
<sup>+/+</sup> and <italic>Pthrp</italic>
<sup>-/-</sup>) from experiments in 1<italic>g</italic> or in simulated microgravity for 6 days, conducted with or without intermittent (2-h daily) PTHrP <sub>1–36</sub> treatment (8 different conditions in total). Data pre-processing and analysis of expressions levels results were conducted using the FlexArray software version 1.5 from Génome Québec [<xref rid="pone.0160034.ref041" ref-type="bibr">41</xref>] <ext-link ext-link-type="uri" xlink:href="http://genomequebec.mcgill.ca/FlexArray">http://genomequebec.mcgill.ca/FlexArray</ext-link>. Normalization was performed with the Lumi package and the data were analyzed using EB Wright and Simon statistical analysis. We retained only gene lists with probe values of p ≤ 0.05 for analysis. Cluster analysis was performed with the Database for Annotation, Visualization and Integrated Discovery online functional annotation tool [<xref rid="pone.0160034.ref042" ref-type="bibr">42</xref>] and by manual searches. Venn diagrams were made using FunRich analysis tool [<xref rid="pone.0160034.ref043" ref-type="bibr">43</xref>]. Microarray data was deposited in the NCBI GEO database and is available under accession number GSE 78980.</p>
              </sec>
              <sec id="sec013">
                <title>Analysis software, statistics</title>
                <p>Statistical analyses of viability experiments were conducted using GraphPad Prism 4.0 for Windows (GraphPad Software, San Diego, CA), using one-way ANOVA with Bonferroni’s multiple comparison post-test. Results were considered significant at p ≤ 0.05.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec014">
              <title>Results</title>
              <sec id="sec015">
                <title>Endogenous PTHrP and exogenous PTHrP<sub>1-36</sub> protect trabecular osteoblasts from Space microgravity-induced apoptosis</title>
                <p>In order to investigate the role of PTHrP in bone cells exposed to space microgravity, trabecular and calvarial osteoblasts obtained from bones of <italic>Pthrp</italic>
<sup>-/-</sup> fetal mice and <italic>Pthrp</italic>
<sup>+/+</sup> littermates [<xref rid="pone.0160034.ref026" ref-type="bibr">26</xref>] were attached to CC2 culture slides and inserted into sterile bioreactors connected online to the automated experimental trays (<xref ref-type="fig" rid="pone.0160034.g001">Fig 1A</xref>). The 6-day experiment involved a daily 2-hour treatment with 10<sup>-8</sup> M PTHrP <sub>1–36</sub> peptide, or a control with growth medium change only for both the 0<italic>g</italic> and 1<italic>g</italic> trays (<xref ref-type="supplementary-material" rid="pone.0160034.s002">S1 Table</xref>). After return to Earth, an analysis of apoptotic cells was conducted by the ssDNA method [<xref rid="pone.0160034.ref037" ref-type="bibr">37</xref>]. A comparison of <italic>Pthrp</italic>
<sup>+/+</sup> TOs in the 1<italic>g</italic> tray with equivalent cells aboard the Foton3 satellite indicates that a 6-day exposure to microgravity causes no significant induction of apoptosis. For <italic>Pthrp</italic>
<sup><italic>-/-</italic></sup> TOs, however, a 20.4 ± 5.0% increase in apoptotic cells was observed at 0<italic>g</italic> over the 6-day period compared to the equivalent <italic>Pthrp</italic>
<sup>-/-</sup> cells which had remained on Earth (<xref ref-type="fig" rid="pone.0160034.g001">Fig 1B</xref> white bars). Intermittent treatment with 10<sup>-8</sup>M PTHrP <sub>1–36</sub> peptide reduced the number of apoptotic cells in 0g compared to 1g by 11.6 ± 4.1% and 50.2% ± 5.4% for <sup>+/+</sup> and <sup>-/-</sup> TOs respectively (<xref ref-type="fig" rid="pone.0160034.g001">Fig 1B</xref> black bars) (p &lt; 0.01). In contrast, over the 6-day period, osteoblasts of calvarial origin (COs) showed little difference in apoptosis due to microgravity exposure although <italic>Pthrp</italic>
<sup><italic>-/-</italic></sup> COs displayed elevated apotosis proportions compared to <sup>+/+</sup> COs regardless of gravity conditions (<xref ref-type="fig" rid="pone.0160034.g001">Fig 1C</xref>). COs were not treated with PTHrP due to the limited reaction volumes available within the experimental trays. These data implicate PTHrP in TO survival in short-term microgravity exposure, and show that in the absence of endogenous PTHrP, intermittent treatment with exogenous PTHrP <sub>1–36</sub> reduces the number of cells undergoing apoptosis.</p>
              </sec>
              <sec id="sec016">
                <title>Allelic effect of endogenous PTHrP levels in simulated microgravity, and compensation by exogenous PTHrP <sub>1–36</sub></title>
                <p>In order to reproduce and expand Space flight results on the role of endogenous and exogenous PTHrP in trabecular octeoblasts, we used the Revolving Cell Culture System Earth-based microgravity simulator from Synthecon (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2A</xref>). TOs from <italic>Pthrp</italic>
<sup>+/+</sup>, <italic>Pthrp</italic>
<sup>+/-</sup> and <italic>Pthrp</italic>
<sup>-/-</sup> fetal animals attached to sterile MicroHex microcarriers (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2B</xref>) spontaneously transformed into three-dimensional structures within 24 h (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2C</xref>) and these aggregates remained intact throughout the experiment. The low negative impact of our design is evident in the excellent survival of various types of osteoblasts in the Synthecon chambers for extended periods of time (see next section).</p>
                <p>Cell-microcarrier aggregates were collected after 6 days, trypsinised and analysed by Trypan blue for viability. After 6 days, <italic>Pthrp</italic><sup>+/+</sup> TOs presented a low (7.5±1.1%) percentage of non-viable cells in both 0<italic>g</italic> and 1<italic>g</italic> experimental set-ups. Heterozygous <italic>Pthrp</italic>
<sup>+/-</sup> TOs displayed a higher percentage of non-viable cells (22% ± 2.1 at 0<italic>g</italic> compared to 13.5±1.9% at 1<italic>g</italic>) p &lt; 0.01, and <italic>Pthrp</italic>
<sup>-/-</sup> TOs were greatly affected by weightlessness (non-viable cells: 43±3.1% at 0<italic>g</italic> compared to 20 ± 2.5% at 1<italic>g</italic>) (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2D</xref> white bars) p &lt; 0.001. Intermittent treatment with PTHrP <sub>1–36</sub> made little difference at 1<italic>g</italic> or 0<italic>g</italic> for <italic>Pthrp</italic><sup>+/+</sup> TOs but reduced the percentage of non-viable cells from 22.1 to 12.7 ± 4% at 0<italic>g</italic> in the heterozygous TOs. In <italic>Pthrp</italic>
<sup>-/-</sup> cells, PTHrP <sub>1–36</sub> intermittent treatment decreased non-viable cells from 20±3.2% to 11±2.5% at 1<italic>g</italic>, but there was a striking reduction (43±4.2% to 11±5.0%) in numbers of non-viable cells at 0<italic>g</italic> (<xref ref-type="fig" rid="pone.0160034.g002">Fig 2D</xref> black bars) p &lt; 0.001. These data confirm the results obtained in Space: there is little to no effect of microgravity on <italic>Pthrp</italic><sup><italic>+/+</italic></sup> cell viability in 0g over 6 days, but incremental loss of viability as <italic>Pthrp</italic> levels of expression decrease. Intermittent PTHrP<sub>1-36</sub> maintains or increases viability, especially in <italic>Pthrp</italic><sup><italic>-/-</italic></sup> TOs. The simulated microgravity experiments demonstrate again the greater vulnerability of <italic>Pthrp</italic>-ablated trabecular osteoblasts to microgravity and point to a definite allelic effect for <italic>Pthrp</italic> ablation.</p>
              </sec>
              <sec id="sec017">
                <title>Long-term exposure to simulated microgravity is detrimental to wild-type trabecular osteoblasts but compensated for by exogenous PTHrP<sub>1-36</sub> treatment</title>
                <p>In order to investigate the effect of longer microgravity exposure on wild-type TOs, 6-week experiments were conducted with wild-type <italic>Pthrp</italic><sup>+/+</sup> TO cells attached to microcarriers and exposed to RCCS-simulated microgravity (0<italic>g</italic>) or to normal gravity (1<italic>g</italic>). Incubation conditions, media changes and intermittent daily PTHrP <sub>1–36</sub> treatments (10<sup>-8</sup> M) were identical to those described above. Samples of osteoblast aggregates on microcarriers were drawn from 1<italic>g</italic> and 0<italic>g</italic> experimental set at weekly intervals, trypsinized, and cell viability assessed by Trypan blue staining. The three-dimensional cell aggregates on micro-carriers provide <italic>in vitro</italic> growth conditions that are closer to those found <italic>in vivo</italic> compared to single layer cultures [<xref rid="pone.0160034.ref044" ref-type="bibr">44</xref>] and allow excellent survival of wild-type trabecular osteoblasts in normal gravity over the course of 6 weeks; wild-type <italic>Pthrp</italic><sup>+/+</sup> TOs attached to MicroHex carriers easily survived 6 weeks in culture plates in normal 1<italic>g</italic> gravity, with only a 10–15% overall loss in viability (<xref ref-type="fig" rid="pone.0160034.g003">Fig 3</xref>). In contrast, <italic>Pthrp</italic><sup>+/+</sup> TOs on MicroHex carriers exposed to simulated microgravity (0<italic>g</italic>) started to lose viability after 2 weeks and presented a striking 50% non-viable cells after 6 weeks. Importantly, a 2-h daily treatment with PTHrP<sub>1-36</sub> over the 6-week period reduced this loss of viability to 15%, similar to that of cells left at 1<italic>g</italic>. As expected from results observed in <xref ref-type="fig" rid="pone.0160034.g002">Fig 2</xref>, <italic>Pthrp</italic><sup><italic>-/-</italic></sup> TOs did not survive past week 2 (not shown). These results suggest that microgravity-induced molecular events leading to cell death occur early in wild-type TOs and that intermittent treatment with PTHrP <sub>1–36</sub> peptide maintains viability in these cells over the course of 6 weeks.</p>
                <fig id="pone.0160034.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>Long-term exposure to simulated microgravity is detrimental to wild-type trabecular osteoblasts but compensated for by exogenous intermittent PTHrP<sub>1-36</sub> treatment.</title>
                    <p><italic>Pthrp</italic><sup><italic>+/+</italic></sup> trabecular osteoblasts at 1<italic>g</italic> (■) or 0<italic>g</italic> (▼). <italic>Pthrp</italic><sup><italic>+/+</italic></sup> trabecular osteoblasts treated with PTHrP<sub>1-36</sub> 10<sup>-8</sup>M.at 1<italic>g</italic> (▲) or 0<italic>g</italic> (♦). (triplicate 6-week experiments). Viability estimated by Trypan blue. ** p &lt; 0.01, *** p &lt; 0.001.</p>
                  </caption>
                  <graphic xlink:href="pone.0160034.g003"/>
                </fig>
              </sec>
              <sec id="sec018">
                <title>Long-term exposure to simulated microgravity has little negative effect on calvarial osteoblasts</title>
                <p>Long-term experiments (6-weeks) were conducted in the RCCS equipment with calvarial osteoblasts from <italic>Pthrp</italic>
<sup>+/+</sup> and <sup>-/-</sup> mice. CO cells attached to MicroHex carriers produced three-dimensional structures similar to those observed in trabecular experiments. Experimental 0<italic>g</italic> and 1<italic>g</italic> conditions were identical to above except that no exogenous PTHrP <sub>1–36</sub> treatment was conducted. <xref ref-type="fig" rid="pone.0160034.g004">Fig 4</xref> shows that COs from wild type <italic>Pthrp</italic>
<sup>+/+</sup> mice maintain comparable viability in 0<italic>g</italic> and 1<italic>g</italic> for at least 6 weeks (10 to 12% non-viable cells). As suggested by results from <xref ref-type="fig" rid="pone.0160034.g001">Fig 1C</xref>, <italic>Pthrp</italic>
<sup>-/-</sup> COs are more sensitive to 0g but the percentage of non-viable cells after 6 weeks at 0<italic>g</italic> is only 13% above that of <italic>Pthrp</italic>
<sup>-/-</sup> calvarial cells at 1<italic>g</italic>. These results indicate that wild-type COs are little affected by a 6-week exposure to microgravity, but that PTHrP nevertheless plays some role in resistance to weightlessness in cranium-derived osteoblasts since <italic>Pthrp</italic>
<sup>-/-</sup> calvarial cells slowly lose viability in 0<italic>g</italic>.</p>
                <fig id="pone.0160034.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Long-term exposure to simulated microgravity has little negative effect on calvarial osteoblasts.</title>
                    <p><italic>Phtrp</italic><sup><italic>+/+</italic></sup> calvarial osteoblasts at 1g (▼) or 0g (■). <italic>Pthrp</italic><sup><italic>-/-</italic></sup> calvarial osteoblasts at 1g (●) or 0g (▲). (triplicate 6-week experiments). No exogenous PTHrP<sub>1-36</sub> treatment was applied in this experiment. Viability estimated by Trypan blue. * p &lt; 0.05, ** p &lt; 0.01.</p>
                  </caption>
                  <graphic xlink:href="pone.0160034.g004"/>
                </fig>
              </sec>
              <sec id="sec019">
                <title>Microarray analysis conducted on trabecular osteoblasts: effect of 6-day exposure to microgravity, effect of <italic>Pthrp</italic> ablation, and reversal by intermittent PTHrP <sub>1–36</sub> treatment</title>
                <p>Microgravity-induced adverse effects appear early on in TOs exposed to weightless conditions. Since these early events are crucial to all subsequent physiological changes, expression microarrays after 6 days at 0<italic>g</italic> were analysed in order to identify the genes involved. Microarray analysis (Illumina Mouse Ref8) was conducted on <italic>Pthrp</italic><sup>+/+</sup> wild type TOs exposed to 6 days of simulated microgravity to check for early gene expression changes that lead to microgravity-induced alterations detectable in the following weeks. 0<italic>g</italic>-induced changes in <italic>Pthrp</italic><sup><italic>+/+</italic></sup> TOs were also compared with those resulting from <italic>Pthrp</italic> gene ablation. Reversal was examined upon intermittent treatment with the PTHrP<sub>1-36</sub> peptide (10<sup>-8</sup>M) of <italic>Pthrp</italic>-ablated and 0<italic>g</italic>-exposed TO cells.</p>
                <p>In <italic>Pthrp</italic><sup>+/+</sup> trabecular osteoblasts, a 6-day period in simulated microgravity significantly upregulated 59 genes (fold change &gt; 2.0, <italic>p</italic> &lt; 0.05, complete gene list in <xref ref-type="supplementary-material" rid="pone.0160034.s003">S2A Table</xref>), and downregulated 129 genes (fold change &lt; 0.5, <italic>p</italic> &lt; 0.05, complete gene list in <xref ref-type="supplementary-material" rid="pone.0160034.s003">S2B Table</xref>) compared to <italic>Pthrp</italic><sup>+/+</sup> TOs which remained at 1<italic>g</italic> (total number of genes significantly affected by 6 days at 0g = 188). <italic>Pthrp</italic> gene ablation (i.e. comparison of <italic>Pthrp</italic><sup>+/+</sup> and <italic>Pthrp</italic><sup>-/-</sup> TOs at 1<italic>g</italic>) significantly upregulated 270 genes (fold change &gt; 2.0, <italic>p</italic> &lt; 0.05, complete genelist in <xref ref-type="supplementary-material" rid="pone.0160034.s004">S3A Table</xref>) and downregulated 493 genes (fold change &lt; 0.5, <italic>p</italic> &lt; 0.05, complete gene list in <xref ref-type="supplementary-material" rid="pone.0160034.s004">S3B Table</xref>)(total number of genes significantly affected by <italic>Pthrp</italic> ablation = 763).</p>
                <p>With this information, a parallel was established between the effects of microgravity exposure on wild-type <italic>Pthrp</italic><sup>+/+</sup> TOs, and the changes in gene expression occurring after <italic>Pthrp</italic> ablation at 1<italic>g</italic>. 52 upregulated and 115 downregulated genes were found to be common between 0<italic>g</italic> exposure and <italic>Pthrp</italic> ablation effects (<xref ref-type="fig" rid="pone.0160034.g005">Fig 5A and 5B</xref>, intersects, complete list of common genes in Tables <xref rid="pone.0160034.t001" ref-type="table">1</xref> and <xref rid="pone.0160034.t002" ref-type="table">2</xref>). In all, 88% of the genes modified by microgravity were similarly affected by <italic>Pthrp</italic> ablation. Clustering analysis suggests the common genes are mainly related to the following metabolic categories: prolactins (<underline>up</underline>: <italic>Plf2</italic>, <italic>Mrpplf3)</italic>, genes involved in bone growth, mineralization and bone morphogenic protein (BMP) metabolism (<underline>up</underline>: <italic>Aqp5; Grem1</italic>, <italic>Inhba</italic>, <italic>Nbl1</italic>, <italic>Cryab</italic>, <italic>Ank</italic>, <italic>CD44</italic>, <italic>Scx</italic>, <italic>Mustn1</italic>, <italic>Tnfrsf11b</italic> (osteoprotegerin), <italic>Bdnf</italic>, <italic>Stmn2</italic>; <underline>down</underline>: <italic>Ptn</italic> (pleiotrophin), <italic>Hp</italic>, <italic>Scara5</italic>, <italic>Itm2a</italic>, <italic>Ptn</italic>, <italic>Dlk1</italic>, <italic>Ramp2</italic>, <italic>Dab</italic>, <italic>Eno1</italic>, <italic>CD14</italic>, <italic>Hemp1</italic>, <italic>Lgmn</italic>, <italic>Txnip</italic>, <italic>Ptx3)</italic>, apoptosis/survival (<underline>down</underline>: <italic>Clu</italic>, <italic>Rbm3</italic>), extracellular matrix components (<underline>up</underline>: <italic>Timp3</italic>, <italic>Prelp</italic>, <italic>Ctgf</italic>, <italic>Col7a1</italic>; <underline>down</underline>: <italic>Lum</italic>, <italic>Dcn</italic>, <italic>H19</italic>, <italic>Nid2</italic>, <italic>Col3a1</italic>, <italic>Dpt</italic>, <italic>Ctsc</italic>), Wnt signaling (<underline>up</underline>: <italic>Gpc1</italic>, <italic>Nkd2</italic>; <underline>down</underline>: <italic>Sfrp 2</italic> and <italic>1</italic>), IGF signaling (<underline>down</underline>: <italic>Igfbp5</italic> and <italic>3</italic>, <italic>Igf2</italic>), heat-shock proteins (<underline>up</underline>: <italic>Hspb1</italic> and <italic>8</italic>), chemokines (<underline>down</underline>: <italic>Cxcl12</italic> and <italic>4</italic>, <italic>Ccr5</italic>), cell cycle control (<underline>up</underline>: <italic>Ccng1</italic>, <underline>down</underline>: <italic>Cdkn1c</italic>), as well as a variety of histone genes. Importantly, none of the significantly-affected genes presented a contradictory direction change in expression level between <italic>Pthrp</italic> ablation or microgravity treatment.</p>
                <fig id="pone.0160034.g005" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <title>Venn diagrams illustrating the number of trabecular osteoblast genes significantly up- or downregulated by microgravity exposure (6 days) or by <italic>Pthrp</italic> ablation, and reversed by PTHrP<sub>1-36</sub> treatment.</title>
                    <p><bold>(A)</bold> 52 genes are upregulated by both 0g (yellow) and <italic>Pthrp</italic> ablation (blue). Fold change &gt; 2.0, <italic>p</italic> &lt; 0.05. <bold>(B)</bold> 115 genes are downregulated by both 0<italic>g</italic> (yellow) and <italic>Pthrp</italic> ablation (blue). Fold change &lt; 0.5, <italic>p</italic> &lt; 0.05. <bold>(C)</bold> 24 genes are upregulated by both 0g (yellow) and <italic>Pthrp</italic> ablation (blue), and are also downregulated (central intersect) by PTHrP<sub>1-36</sub> treatment (red). Fold change &lt; 0.65, <italic>p</italic> &lt; 0.05. <bold>(D)</bold> 50 genes are downregulated by both 0<italic>g</italic> (yellow) and <italic>Pthrp</italic> ablation (blue), and upregulated (central intersect) by PTHrP<sub>1-36</sub> treatment (red). Fold change &gt;1.5, <italic>p</italic> &lt; 0.05.</p>
                  </caption>
                  <graphic xlink:href="pone.0160034.g005"/>
                </fig>
                <table-wrap id="pone.0160034.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Genes (52) upregulated by both microgravity and <italic>Pthrp</italic> ablation.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0160034.t001g" xlink:href="pone.0160034.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Target ID</th>
                          <th align="left" rowspan="1" colspan="1">Definition (all probes: <italic>Mus musculus</italic>)</th>
                          <th align="left" rowspan="1" colspan="1">RefSeq ID</th>
                          <th align="left" rowspan="1" colspan="1">Fold change 0g</th>
                          <th align="left" rowspan="1" colspan="1">Fold change ablation</th>
                          <th align="left" rowspan="1" colspan="1">C</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PLF2</td>
                          <td align="left" rowspan="1" colspan="1">prolactin family 2, subfamily c, member 3 (Prl2c3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011118.1</td>
                          <td align="right" rowspan="1" colspan="1">12.81098</td>
                          <td align="right" rowspan="1" colspan="1">20.67081</td>
                          <td align="left" rowspan="1" colspan="1">P</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MRPPLF3</td>
                          <td align="left" rowspan="1" colspan="1">prolactin family 2, subfamily c, member 4 (Prl2c4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011954.2</td>
                          <td align="right" rowspan="1" colspan="1">11.76853</td>
                          <td align="right" rowspan="1" colspan="1">19.04649</td>
                          <td align="left" rowspan="1" colspan="1">P</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">AQP5</td>
                          <td align="left" rowspan="1" colspan="1">aquaporin 5 (Aqp5), mRNA.PREDICTED: similar to aquaporin 5 (LOC100046616), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009701.4XM_001476512.1</td>
                          <td align="right" rowspan="1" colspan="1">7.7909763.627969</td>
                          <td align="right" rowspan="1" colspan="1">25.586929.547247</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GREM1</td>
                          <td align="left" rowspan="1" colspan="1">gremlin1 (Grem1) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011824.1</td>
                          <td align="right" rowspan="1" colspan="1">4.151464</td>
                          <td align="right" rowspan="1" colspan="1">5.17375</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GPC1</td>
                          <td align="left" rowspan="1" colspan="1">glypican 1 (Gpc1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_016696.3</td>
                          <td align="right" rowspan="1" colspan="1">4.13393</td>
                          <td align="right" rowspan="1" colspan="1">4.008327</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ALDH3A1</td>
                          <td align="left" rowspan="1" colspan="1">aldehyde dehydrogenase family 3, subfamily A1 (Aldh3a1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007436.1</td>
                          <td align="right" rowspan="1" colspan="1">3.821048</td>
                          <td align="right" rowspan="1" colspan="1">2.733907</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ASS1</td>
                          <td align="left" rowspan="1" colspan="1">argininosuccinate synthetase 1 (Ass1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007494.3</td>
                          <td align="right" rowspan="1" colspan="1">3.663361</td>
                          <td align="right" rowspan="1" colspan="1">2.781254</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NKD2</td>
                          <td align="left" rowspan="1" colspan="1">naked cuticle 2 homolog (Drosophila) (Nkd2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_028186.3</td>
                          <td align="right" rowspan="1" colspan="1">3.63063</td>
                          <td align="right" rowspan="1" colspan="1">9.964373</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NQO1</td>
                          <td align="left" rowspan="1" colspan="1">NAD(P)H dehydrogenase, quinone 1 (Nqo1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008706.4</td>
                          <td align="right" rowspan="1" colspan="1">3.439677</td>
                          <td align="right" rowspan="1" colspan="1">9.410905</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">INHBA</td>
                          <td align="left" rowspan="1" colspan="1">inhibin beta-A (Inhba), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008380.1</td>
                          <td align="right" rowspan="1" colspan="1">3.374437</td>
                          <td align="right" rowspan="1" colspan="1">6.03861</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H4H</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H4h (Hist1h4h), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_153173.2</td>
                          <td align="right" rowspan="1" colspan="1">3.122563</td>
                          <td align="right" rowspan="1" colspan="1">6.525515</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HSPB1</td>
                          <td align="left" rowspan="1" colspan="1">heat shock protein 1 (Hspb1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013560.1</td>
                          <td align="right" rowspan="1" colspan="1">2.937195</td>
                          <td align="right" rowspan="1" colspan="1">3.686913</td>
                          <td align="left" rowspan="1" colspan="1">HS</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CRIP2</td>
                          <td align="left" rowspan="1" colspan="1">cysteine rich protein 2 (Crip2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_024223.1</td>
                          <td align="right" rowspan="1" colspan="1">2.87678</td>
                          <td align="right" rowspan="1" colspan="1">4.260978</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TIMP3</td>
                          <td align="left" rowspan="1" colspan="1">tissue inhibitor of metalloproteinase 3 (Timp3), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_011595.2NM_011595.2</td>
                          <td align="right" rowspan="1" colspan="1">2.8337662.168426</td>
                          <td align="right" rowspan="1" colspan="1">4.7180244.573879</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ESD</td>
                          <td align="left" rowspan="1" colspan="1">esterase D/formylglutathione hydrolase (Esd), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_016903.2</td>
                          <td align="right" rowspan="1" colspan="1">2.617979</td>
                          <td align="right" rowspan="1" colspan="1">4.782361</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PRELP</td>
                          <td align="left" rowspan="1" colspan="1">proline arginine-rich end leucine-rich repeat (Prelp), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_054077.3</td>
                          <td align="right" rowspan="1" colspan="1">2.563206</td>
                          <td align="right" rowspan="1" colspan="1">2.682429</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1110032E23RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 1110032E23 gene (1110032E23Rik), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_133187.2</td>
                          <td align="right" rowspan="1" colspan="1">2.532211</td>
                          <td align="right" rowspan="1" colspan="1">5.501027</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GDF15</td>
                          <td align="left" rowspan="1" colspan="1">growth differentiation factor 15 (Gdf15), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011819.1</td>
                          <td align="right" rowspan="1" colspan="1">2.506674</td>
                          <td align="right" rowspan="1" colspan="1">2.841855</td>
                          <td align="left" rowspan="1" colspan="1">T</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">AHRR</td>
                          <td align="left" rowspan="1" colspan="1">aryl-hydrocarbon receptor repressor (Ahrr), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009644.2</td>
                          <td align="right" rowspan="1" colspan="1">2.366026</td>
                          <td align="right" rowspan="1" colspan="1">2.51242</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NBL1</td>
                          <td align="left" rowspan="1" colspan="1">neuroblastoma, suppression of tumorigenicity 1 (Nbl1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008675.1</td>
                          <td align="right" rowspan="1" colspan="1">2.362421</td>
                          <td align="right" rowspan="1" colspan="1">2.214473</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CRYAB</td>
                          <td align="left" rowspan="1" colspan="1">crystallin, alpha B (Cryab), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009964.1</td>
                          <td align="right" rowspan="1" colspan="1">2.332638</td>
                          <td align="right" rowspan="1" colspan="1">5.135748</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">FABP3</td>
                          <td align="left" rowspan="1" colspan="1">fatty acid binding protein 3, muscle and heart (Fabp3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010174.1</td>
                          <td align="right" rowspan="1" colspan="1">2.32906</td>
                          <td align="right" rowspan="1" colspan="1">7.70136</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MDM2</td>
                          <td align="left" rowspan="1" colspan="1">transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010786.2NM_010786.3</td>
                          <td align="right" rowspan="1" colspan="1">2.318342.246531</td>
                          <td align="right" rowspan="1" colspan="1">2.8090142.71183</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">KCTD10</td>
                          <td align="left" rowspan="1" colspan="1">potassium channel tetramerisation domain containing 10 (Kctd10), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_026145.3</td>
                          <td align="right" rowspan="1" colspan="1">2.279135</td>
                          <td align="right" rowspan="1" colspan="1">2.72172</td>
                          <td align="left" rowspan="1" colspan="1">IC</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SGK</td>
                          <td align="left" rowspan="1" colspan="1">serum/glucocorticoid regulated kinase 1 (Sgk1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011361.1</td>
                          <td align="right" rowspan="1" colspan="1">2.240079</td>
                          <td align="right" rowspan="1" colspan="1">2.362139</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ANK</td>
                          <td align="left" rowspan="1" colspan="1">progressive ankylosis (Ank), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_020332.3</td>
                          <td align="right" rowspan="1" colspan="1">2.228785</td>
                          <td align="right" rowspan="1" colspan="1">9.115022</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EPHX1</td>
                          <td align="left" rowspan="1" colspan="1">epoxide hydrolase 1, microsomal (Ephx1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010145.2</td>
                          <td align="right" rowspan="1" colspan="1">2.215451</td>
                          <td align="right" rowspan="1" colspan="1">2.907278</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">WHRN</td>
                          <td align="left" rowspan="1" colspan="1">whirlin (Whrn), transcript variant 3, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001008792.1</td>
                          <td align="right" rowspan="1" colspan="1">2.202689</td>
                          <td align="right" rowspan="1" colspan="1">2.327795</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CD44</td>
                          <td align="left" rowspan="1" colspan="1">CD44 antigen (Cd44), transcript variant 2, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001039150.1</td>
                          <td align="right" rowspan="1" colspan="1">2.195092</td>
                          <td align="right" rowspan="1" colspan="1">4.927895</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CTGF</td>
                          <td align="left" rowspan="1" colspan="1">connective tissue growth factor (Ctgf), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010217.1</td>
                          <td align="right" rowspan="1" colspan="1">2.193812</td>
                          <td align="right" rowspan="1" colspan="1">3.29075</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCX</td>
                          <td align="left" rowspan="1" colspan="1">scleraxis (Scx), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_198885.2</td>
                          <td align="right" rowspan="1" colspan="1">2.185468</td>
                          <td align="right" rowspan="1" colspan="1">4.251521</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MUSTN1</td>
                          <td align="left" rowspan="1" colspan="1">musculoskeletal, embryonic nuclear protein 1 (Mustn1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_181390.1NM_181390.2</td>
                          <td align="right" rowspan="1" colspan="1">2.1853642.109783</td>
                          <td align="right" rowspan="1" colspan="1">3.9570883.099647</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2BJ</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2bj (Hist1h2bj), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178198.1</td>
                          <td align="right" rowspan="1" colspan="1">2.173656</td>
                          <td align="right" rowspan="1" colspan="1">2.755197</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EEF1A2</td>
                          <td align="left" rowspan="1" colspan="1">eukaryotic translation elongation factor 1 alpha 2 (Eef1a2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007906.2</td>
                          <td align="right" rowspan="1" colspan="1">2.153269</td>
                          <td align="right" rowspan="1" colspan="1">2.293173</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TNFRSF11B</td>
                          <td align="left" rowspan="1" colspan="1">tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (Tnfrsf11b), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008764.3</td>
                          <td align="right" rowspan="1" colspan="1">2.129809</td>
                          <td align="right" rowspan="1" colspan="1">9.058214</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HOXC6</td>
                          <td align="left" rowspan="1" colspan="1">homeo box C6 (Hoxc6), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010465.2</td>
                          <td align="right" rowspan="1" colspan="1">2.107019</td>
                          <td align="right" rowspan="1" colspan="1">2.215212</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2300002D11RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 2300002D11 gene (2300002D11Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001081156.1</td>
                          <td align="right" rowspan="1" colspan="1">2.097322</td>
                          <td align="right" rowspan="1" colspan="1">4.2774</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">BDNF</td>
                          <td align="left" rowspan="1" colspan="1">brain derived neurotrophic factor (Bdnf), transcript variant 3, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001048141.1</td>
                          <td align="right" rowspan="1" colspan="1">2.091327</td>
                          <td align="right" rowspan="1" colspan="1">7.461118</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HSPB8</td>
                          <td align="left" rowspan="1" colspan="1">heat shock protein 8 (Hspb8), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_030704.1</td>
                          <td align="right" rowspan="1" colspan="1">2.090601</td>
                          <td align="right" rowspan="1" colspan="1">2.42948</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PDGFA</td>
                          <td align="left" rowspan="1" colspan="1">platelet-derived growth factor, alpha chain (Pdgfa) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="right" rowspan="1" colspan="1">2.084386</td>
                          <td align="right" rowspan="1" colspan="1">2.631637</td>
                          <td align="left" rowspan="1" colspan="1">PD</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CCNG1</td>
                          <td align="left" rowspan="1" colspan="1">cyclin G1 (Ccng1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009831.2</td>
                          <td align="right" rowspan="1" colspan="1">2.083259</td>
                          <td align="right" rowspan="1" colspan="1">3.109058</td>
                          <td align="left" rowspan="1" colspan="1">CC</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2BM</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2bm (Hist1h2bm), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178200.1</td>
                          <td align="right" rowspan="1" colspan="1">2.072647</td>
                          <td align="right" rowspan="1" colspan="1">2.824912</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2BH</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2bh (Hist1h2bh), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178197.1</td>
                          <td align="right" rowspan="1" colspan="1">2.069317</td>
                          <td align="right" rowspan="1" colspan="1">2.693571</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2BF</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2bf (Hist1h2bf), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178195.1</td>
                          <td align="right" rowspan="1" colspan="1">2.066524</td>
                          <td align="right" rowspan="1" colspan="1">2.55937</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COL7A1</td>
                          <td align="left" rowspan="1" colspan="1">collagen, type VII, alpha 1 (Col7a1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007738.3</td>
                          <td align="right" rowspan="1" colspan="1">2.044317</td>
                          <td align="right" rowspan="1" colspan="1">3.129226</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">A630005A06RIK</td>
                          <td align="left" rowspan="1" colspan="1">TBC1 domain family, member 2 (Tbc1d2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_198664.3</td>
                          <td align="right" rowspan="1" colspan="1">2.044002</td>
                          <td align="right" rowspan="1" colspan="1">3.518042</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GSTP1</td>
                          <td align="left" rowspan="1" colspan="1">glutathione S-transferase, pi 1 (Gstp1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013541.1</td>
                          <td align="right" rowspan="1" colspan="1">2.039079</td>
                          <td align="right" rowspan="1" colspan="1">2.672256</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TNFRSF12A</td>
                          <td align="left" rowspan="1" colspan="1">tumor necrosis factor receptor superfamily, member 12a (Tnfrsf12a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013749.1</td>
                          <td align="right" rowspan="1" colspan="1">2.026671</td>
                          <td align="right" rowspan="1" colspan="1">3.449432</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SNRPN</td>
                          <td align="left" rowspan="1" colspan="1">SNRPN upstream reading frame (Snurf), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_033174.2</td>
                          <td align="right" rowspan="1" colspan="1">2.014161</td>
                          <td align="right" rowspan="1" colspan="1">3.736806</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2BK</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2bk (Hist1h2bk), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175665.1</td>
                          <td align="right" rowspan="1" colspan="1">2.012974</td>
                          <td align="right" rowspan="1" colspan="1">2.669902</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">STMN2</td>
                          <td align="left" rowspan="1" colspan="1">stathmin-like 2 (Stmn2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_025285.2</td>
                          <td align="right" rowspan="1" colspan="1">2.007183</td>
                          <td align="right" rowspan="1" colspan="1">3.763786</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DOS</td>
                          <td align="left" rowspan="1" colspan="1">downstream of Stk11 (Dos), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_015761.2</td>
                          <td align="right" rowspan="1" colspan="1">2.00261</td>
                          <td align="right" rowspan="1" colspan="1">3.474366</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p>Genes (52) upregulated by both microgravity and <italic>Pthrp</italic> ablation. All fold changes &gt; 2. All p values &lt; 0.05. Multiple entries for a gene indicate multiple probes. C: Clustering: A: apoptosis/survival, B: bone metabolism and bone morphogenic proteins, CC: cell cycle, E: extracellular matrix, H: histone, HS: heat shock, IC: ion channel, P: prolactins, PD: Platelet-derived growth factor, T: tumor growth factor, W: Wnt.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="pone.0160034.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Genes (115) downregulated by both microgravity and <italic>Pthrp</italic> ablation.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0160034.t002g" xlink:href="pone.0160034.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Target ID</th>
                          <th align="left" rowspan="1" colspan="1">Definition (all probes: <italic>Mus musculus</italic>)</th>
                          <th align="left" rowspan="1" colspan="1">RefSeq ID</th>
                          <th align="left" rowspan="1" colspan="1">Fold change 0g</th>
                          <th align="left" rowspan="1" colspan="1">Fold change ablation</th>
                          <th align="left" rowspan="1" colspan="1">C</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SFRP2</td>
                          <td align="left" rowspan="1" colspan="1">secreted frizzled-related protein 2 (Sfrp2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009144.1</td>
                          <td align="right" rowspan="1" colspan="1">0.1316429</td>
                          <td align="right" rowspan="1" colspan="1">0.096523</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PTN</td>
                          <td align="left" rowspan="1" colspan="1">pleiotrophin (Ptn), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008973.2</td>
                          <td align="right" rowspan="1" colspan="1">0.1557338</td>
                          <td align="right" rowspan="1" colspan="1">0.047141</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">IGFBP5</td>
                          <td align="left" rowspan="1" colspan="1">insulin-like growth factor binding protein 5 (Igfbp5), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010518.2</td>
                          <td align="right" rowspan="1" colspan="1">0.1603545</td>
                          <td align="right" rowspan="1" colspan="1">0.2130594</td>
                          <td align="left" rowspan="1" colspan="1">I</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1500015O10RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 1500015O10 gene (1500015O10Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_024283.2</td>
                          <td align="right" rowspan="1" colspan="1">0.1804316</td>
                          <td align="right" rowspan="1" colspan="1">0.0975587</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">IGF2</td>
                          <td align="left" rowspan="1" colspan="1">insulin-like growth factor 2 (Igf2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010514.2</td>
                          <td align="right" rowspan="1" colspan="1">0.2085582</td>
                          <td align="right" rowspan="1" colspan="1">0.026108</td>
                          <td align="left" rowspan="1" colspan="1">I</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CLU</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: similar to clusterin (LOC100046120), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">XM_001475611.1</td>
                          <td align="right" rowspan="1" colspan="1">0.213665</td>
                          <td align="right" rowspan="1" colspan="1">0.47421</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CXCL12</td>
                          <td align="left" rowspan="1" colspan="1">chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 3, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013655.2NM_021704.2NM_001012477.1</td>
                          <td align="right" rowspan="1" colspan="1">0.21502010.22348560.236011</td>
                          <td align="right" rowspan="1" colspan="1">0.28323790.40775260.3778157</td>
                          <td align="left" rowspan="1" colspan="1">CH</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HP</td>
                          <td align="left" rowspan="1" colspan="1">haptoglobin (Hp), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_017370.1NM_017370.1</td>
                          <td align="right" rowspan="1" colspan="1">0.22221020.4034571</td>
                          <td align="right" rowspan="1" colspan="1">0.18333460.4167181</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C3</td>
                          <td align="left" rowspan="1" colspan="1">complement 3 (C3) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009778.1</td>
                          <td align="right" rowspan="1" colspan="1">0.2325967</td>
                          <td align="right" rowspan="1" colspan="1">0.1254136</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCARA5</td>
                          <td align="left" rowspan="1" colspan="1">scavenger receptor class A, member 5 (putative) (Scara5), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_028903.1</td>
                          <td align="right" rowspan="1" colspan="1">0.2351416</td>
                          <td align="right" rowspan="1" colspan="1">0.1405516</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LUM</td>
                          <td align="left" rowspan="1" colspan="1">lumican (Lum), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008524.1</td>
                          <td align="right" rowspan="1" colspan="1">0.235224</td>
                          <td align="right" rowspan="1" colspan="1">0.0573447</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MRC1</td>
                          <td align="left" rowspan="1" colspan="1">mannose receptor, C type 1 (Mrc1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008625.1</td>
                          <td align="right" rowspan="1" colspan="1">0.253038</td>
                          <td align="right" rowspan="1" colspan="1">0.0815048</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">4930583H14RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 4930583H14 gene (4930583H14Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_026358.2</td>
                          <td align="right" rowspan="1" colspan="1">0.2575598</td>
                          <td align="right" rowspan="1" colspan="1">0.1684547</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2310061N23RIK</td>
                          <td align="left" rowspan="1" colspan="1">interferon, alpha-inducible protein 27 (Ifi27), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_029803.1</td>
                          <td align="right" rowspan="1" colspan="1">0.2600992</td>
                          <td align="right" rowspan="1" colspan="1">0.0590283</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DCN</td>
                          <td align="left" rowspan="1" colspan="1">decorin (Dcn), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007833.4NM_007833.4</td>
                          <td align="right" rowspan="1" colspan="1">0.28897940.3837174</td>
                          <td align="right" rowspan="1" colspan="1">0.06403410.0548521</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">H19</td>
                          <td align="left" rowspan="1" colspan="1">H19 fetal liver mRNA (H19), non-coding RNA.</td>
                          <td align="left" rowspan="1" colspan="1">NR_001592.1</td>
                          <td align="right" rowspan="1" colspan="1">0.2906019</td>
                          <td align="right" rowspan="1" colspan="1">0.0360464</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PPP1R3C</td>
                          <td align="left" rowspan="1" colspan="1">protein phosphatase 1, regulatory (inhibitor) subunit 3C (Ppp1r3c), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_016854.2</td>
                          <td align="right" rowspan="1" colspan="1">0.2954025</td>
                          <td align="right" rowspan="1" colspan="1">0.1777717</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RBM3</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: similar to RNA binding motif protein 3 (LOC100043257), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">XM_001480197.1</td>
                          <td align="right" rowspan="1" colspan="1">0.2991486</td>
                          <td align="right" rowspan="1" colspan="1">0.2378549</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">APOD</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: similar to apolipoprotein D (LOC100047583), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">XM_001479138.1</td>
                          <td align="right" rowspan="1" colspan="1">0.2996465</td>
                          <td align="right" rowspan="1" colspan="1">0.1742532</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ITM2A</td>
                          <td align="left" rowspan="1" colspan="1">integral membrane protein 2A (Itm2a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008409.2</td>
                          <td align="right" rowspan="1" colspan="1">0.2997355</td>
                          <td align="right" rowspan="1" colspan="1">0.138948</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">D930038M13RIK</td>
                          <td align="left" rowspan="1" colspan="1">ABI gene family, member 3 (NESH) binding protein (Abi3bp), transcript variant 1, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178790.3</td>
                          <td align="right" rowspan="1" colspan="1">0.3036303</td>
                          <td align="right" rowspan="1" colspan="1">0.2955018</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PFKL</td>
                          <td align="left" rowspan="1" colspan="1">phosphofructokinase, liver, B-type (Pfkl), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008826.3</td>
                          <td align="right" rowspan="1" colspan="1">0.3054363</td>
                          <td align="right" rowspan="1" colspan="1">0.2514627</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">OLFML1</td>
                          <td align="left" rowspan="1" colspan="1">olfactomedin-like 1 (Olfml1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_172907.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3123395</td>
                          <td align="right" rowspan="1" colspan="1">0.3050197</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AD</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ad (Hist1h2ad), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178188.3</td>
                          <td align="right" rowspan="1" colspan="1">0.3149356</td>
                          <td align="right" rowspan="1" colspan="1">0.0061305</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DLK1</td>
                          <td align="left" rowspan="1" colspan="1">delta-like 1 homolog (Drosophila) (Dlk1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010052.4</td>
                          <td align="right" rowspan="1" colspan="1">0.3273854</td>
                          <td align="right" rowspan="1" colspan="1">0.1513731</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AK</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ak (Hist1h2ak), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178183.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3372404</td>
                          <td align="right" rowspan="1" colspan="1">0.0596174</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2310056P07RIK</td>
                          <td align="left" rowspan="1" colspan="1">family with sequence similarity 162, member A (Fam162a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_027342.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3391683</td>
                          <td align="right" rowspan="1" colspan="1">0.2567712</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AF</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2af (Hist1h2af), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175661.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3396376</td>
                          <td align="right" rowspan="1" colspan="1">0.067387</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SLC1A3</td>
                          <td align="left" rowspan="1" colspan="1">solute carrier family 1 (glial high affinity glutamate transporter), member 3 (Slc1a3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_148938.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3399492</td>
                          <td align="right" rowspan="1" colspan="1">0.1181837</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PSCDBP</td>
                          <td align="left" rowspan="1" colspan="1">cytohesin 1 interacting protein (Cytip), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_139200.4</td>
                          <td align="right" rowspan="1" colspan="1">0.3403133</td>
                          <td align="right" rowspan="1" colspan="1">0.1328767</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NID2</td>
                          <td align="left" rowspan="1" colspan="1">nidogen 2 (Nid2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008695.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3477556</td>
                          <td align="right" rowspan="1" colspan="1">0.3321977</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TGFBI</td>
                          <td align="left" rowspan="1" colspan="1">transforming growth factor, beta induced (Tgfbi), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009369.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3514812</td>
                          <td align="right" rowspan="1" colspan="1">0.0792747</td>
                          <td align="left" rowspan="1" colspan="1">T</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AH</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ah (Hist1h2ah), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175659.1</td>
                          <td align="right" rowspan="1" colspan="1">0.352093</td>
                          <td align="right" rowspan="1" colspan="1">0.0777217</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">FMO1</td>
                          <td align="left" rowspan="1" colspan="1">flavin containing monooxygenase 1 (Fmo1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010231.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3568025</td>
                          <td align="right" rowspan="1" colspan="1">0.3366457</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EGLN3</td>
                          <td align="left" rowspan="1" colspan="1">EGL nine homolog 3 (C. elegans) (Egln3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_028133.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3569504</td>
                          <td align="right" rowspan="1" colspan="1">0.3106277</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DPEP2</td>
                          <td align="left" rowspan="1" colspan="1">dipeptidase 2 (Dpep2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_176913.3</td>
                          <td align="right" rowspan="1" colspan="1">0.35774720.3965119</td>
                          <td align="right" rowspan="1" colspan="1">0.14003250.18665</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COL3A1</td>
                          <td align="left" rowspan="1" colspan="1">collagen, type III, alpha 1 (Col3a1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009930.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3599768</td>
                          <td align="right" rowspan="1" colspan="1">0.2207009</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1200009O22RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 1200009O22 gene (1200009O22Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_025817.3</td>
                          <td align="right" rowspan="1" colspan="1">0.3616481</td>
                          <td align="right" rowspan="1" colspan="1">0.3116025</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AO</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ao (Hist1h2ao), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178185.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3618695</td>
                          <td align="right" rowspan="1" colspan="1">0.057145</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">AGTR1A</td>
                          <td align="left" rowspan="1" colspan="1">angiotensin II receptor, type 1a (Agtr1a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_177322.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3640873</td>
                          <td align="right" rowspan="1" colspan="1">0.3477361</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LDB2</td>
                          <td align="left" rowspan="1" colspan="1">LIM domain-binding protein 2 (Ldb2) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010698.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3694307</td>
                          <td align="right" rowspan="1" colspan="1">0.2963222</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DPT</td>
                          <td align="left" rowspan="1" colspan="1">dermatopontin (Dpt), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_019759.2</td>
                          <td align="right" rowspan="1" colspan="1">0.369822</td>
                          <td align="right" rowspan="1" colspan="1">0.2973928</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">6330406I15RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 6330406I15 gene (6330406I15Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_027519.1NM_027519.3</td>
                          <td align="right" rowspan="1" colspan="1">0.37182430.3991528</td>
                          <td align="right" rowspan="1" colspan="1">0.19828060.2041744</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RASSF4</td>
                          <td align="left" rowspan="1" colspan="1">Ras association (RalGDS/AF-6) domain family member 4 (Rassf4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178045.3NM_178045.3</td>
                          <td align="right" rowspan="1" colspan="1">0.3723380.3845508</td>
                          <td align="right" rowspan="1" colspan="1">0.36712360.1214973</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PDGFRA</td>
                          <td align="left" rowspan="1" colspan="1">platelet derived growth factor receptor, alpha polypeptide (Pdgfra), transcript variant 1, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011058.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3755132</td>
                          <td align="right" rowspan="1" colspan="1">0.394926</td>
                          <td align="left" rowspan="1" colspan="1">PD</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AN</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2an (Hist1h2an), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178184.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3776532</td>
                          <td align="right" rowspan="1" colspan="1">0.0945669</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ZCCH5</td>
                          <td align="left" rowspan="1" colspan="1">Zinc finger, CCHC domain-containing 5 (Zcchc5), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_199468.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3839341</td>
                          <td align="right" rowspan="1" colspan="1">0.4813192</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">IGFBP3</td>
                          <td align="left" rowspan="1" colspan="1">insulin-like growth factor binding protein 3 (Igfbp3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008343.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3878084</td>
                          <td align="right" rowspan="1" colspan="1">0.3767934</td>
                          <td align="left" rowspan="1" colspan="1">I</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">AOC3</td>
                          <td align="left" rowspan="1" colspan="1">amine oxidase, copper containing 3 (Aoc3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009675.1</td>
                          <td align="right" rowspan="1" colspan="1">0.390921</td>
                          <td align="right" rowspan="1" colspan="1">0.102008</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">KNG1</td>
                          <td align="left" rowspan="1" colspan="1">kininogen 1 (Kng1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_023125.2</td>
                          <td align="right" rowspan="1" colspan="1">0.3914529</td>
                          <td align="right" rowspan="1" colspan="1">0.2682237</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SERPING1</td>
                          <td align="left" rowspan="1" colspan="1">serine (or cysteine) peptidase inhibitor, clade G, member 1 (Serping1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009776.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3939361</td>
                          <td align="right" rowspan="1" colspan="1">0.2493484</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SFRP1</td>
                          <td align="left" rowspan="1" colspan="1">secreted frizzled-related protein 1 (Sfrp1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013834.1</td>
                          <td align="right" rowspan="1" colspan="1">0.3966504</td>
                          <td align="right" rowspan="1" colspan="1">0.1332278</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EMR1</td>
                          <td align="left" rowspan="1" colspan="1">EGF-like module containing, mucin-like, hormone receptor-like sequence 1 (Emr1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010130.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4002873</td>
                          <td align="right" rowspan="1" colspan="1">0.0452258</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SIRPB1</td>
                          <td align="left" rowspan="1" colspan="1">signal-regulatory protein beta 1 (Sirpb1), transcript variant 3, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001002898.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4006563</td>
                          <td align="right" rowspan="1" colspan="1">0.250706</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CAR9</td>
                          <td align="left" rowspan="1" colspan="1">carbonic anhydrase 9 (Car9), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_139305.1</td>
                          <td align="right" rowspan="1" colspan="1">0.401926</td>
                          <td align="right" rowspan="1" colspan="1">0.3807879</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SRPX</td>
                          <td align="left" rowspan="1" colspan="1">sushi-repeat-containing protein (Srpx), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_016911.4NM_016911.4</td>
                          <td align="right" rowspan="1" colspan="1">0.40437110.4169736</td>
                          <td align="right" rowspan="1" colspan="1">0.12827860.1438187</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LBP</td>
                          <td align="left" rowspan="1" colspan="1">lipopolysaccharide binding protein (Lbp), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008489.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4046987</td>
                          <td align="right" rowspan="1" colspan="1">0.3596355</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2310006J04RIK</td>
                          <td align="left" rowspan="1" colspan="1">Ankyrin repeat domain 37 (Ankrd 37), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_001039562.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4075139</td>
                          <td align="right" rowspan="1" colspan="1">0.4461992</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CCR5</td>
                          <td align="left" rowspan="1" colspan="1">chemokine (C-C motif) receptor 5 (Ccr5), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009917.2NM_009917.2NM_009917.4</td>
                          <td align="right" rowspan="1" colspan="1">0.40916990.44612370.4461237</td>
                          <td align="right" rowspan="1" colspan="1">0.31747080.32485210.3880605</td>
                          <td align="left" rowspan="1" colspan="1">CH</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RAMP2</td>
                          <td align="left" rowspan="1" colspan="1">receptor (calcitonin) activity modifying protein 2 (Ramp2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_019444.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4105468</td>
                          <td align="right" rowspan="1" colspan="1">0.2878545</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LSP1</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: predicted gene, ENSMUSG00000043795 (ENSMUSG00000043795), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">XM_001480835.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4114556</td>
                          <td align="right" rowspan="1" colspan="1">0.1243922</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CDKN1C</td>
                          <td align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 1C (P57) (Cdkn1c), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009876.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4116614</td>
                          <td align="right" rowspan="1" colspan="1">0.347614</td>
                          <td align="left" rowspan="1" colspan="1">CC</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CORO1A</td>
                          <td align="left" rowspan="1" colspan="1">coronin, actin binding protein 1A (Coro1a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009898.2NM_009898.2NM_009898.2</td>
                          <td align="right" rowspan="1" colspan="1">0.41277540.44359450.4970813</td>
                          <td align="right" rowspan="1" colspan="1">0.08707340.05964910.1696803</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C1QA</td>
                          <td align="left" rowspan="1" colspan="1">complement component 1, q subcomponent, alpha polypeptide (C1qa), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007572.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4128893</td>
                          <td align="right" rowspan="1" colspan="1">0.1927809</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SLC2A1</td>
                          <td align="left" rowspan="1" colspan="1">solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011400.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4167042</td>
                          <td align="right" rowspan="1" colspan="1">0.2991707</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GPR23</td>
                          <td align="left" rowspan="1" colspan="1">G protein-coupled receptor 23 (Gpr23), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175271.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4254305</td>
                          <td align="right" rowspan="1" colspan="1">0.4447173</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PDK1</td>
                          <td align="left" rowspan="1" colspan="1">pyruvate dehydrogenase kinase, isoenzyme 1 (Pdk1), nuclear gene encoding mitochondrial protein, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_172665.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4255101</td>
                          <td align="right" rowspan="1" colspan="1">0.3667602</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CTSC</td>
                          <td align="left" rowspan="1" colspan="1">cathepsin C (Ctsc), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009982.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4265272</td>
                          <td align="right" rowspan="1" colspan="1">0.0758005</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">OASL2</td>
                          <td align="left" rowspan="1" colspan="1">2'-5' oligoadenylate synthetase-like 2 (Oasl2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011854.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4272569</td>
                          <td align="right" rowspan="1" colspan="1">0.1159377</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C1QB</td>
                          <td align="left" rowspan="1" colspan="1">complement component 1, q subcomponent, beta polypeptide (C1qb), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009777.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4278048</td>
                          <td align="right" rowspan="1" colspan="1">0.0245339</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DAB2</td>
                          <td align="left" rowspan="1" colspan="1">disabled homolog 2 (Drosophila) (Dab2), transcript variant 2, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_023118.1NM_001008702.1</td>
                          <td align="right" rowspan="1" colspan="1">0.42782040.4450885</td>
                          <td align="right" rowspan="1" colspan="1">0.17925610.1341114</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RSPO3</td>
                          <td align="left" rowspan="1" colspan="1">R-spondin 3 homolog (Xenopus laevis) (Rspo3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_028351.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4293909</td>
                          <td align="right" rowspan="1" colspan="1">0.2896171</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MFAP2</td>
                          <td align="left" rowspan="1" colspan="1">microfibrillar-associated protein 2 (Mfap2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008546.2NM_008546.2NM_008546.2</td>
                          <td align="right" rowspan="1" colspan="1">0.42967080.47591550.4945922</td>
                          <td align="right" rowspan="1" colspan="1">0.18086140.25899670.2757687</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GMFG</td>
                          <td align="left" rowspan="1" colspan="1">glia maturation factor, gamma (Gmfg), transcript variant 1, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_022024.2NM_022024.2</td>
                          <td align="right" rowspan="1" colspan="1">0.43023620.4870403</td>
                          <td align="right" rowspan="1" colspan="1">0.203090.2355645</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SELENBP1</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: hypothetical protein LOC100044204 (LOC100044204), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">XM_001471696.1</td>
                          <td align="right" rowspan="1" colspan="1">0.433163</td>
                          <td align="right" rowspan="1" colspan="1">0.2613255</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MEST</td>
                          <td align="left" rowspan="1" colspan="1">mesoderm specific transcript (Mest), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008590.1NM_008590.1</td>
                          <td align="right" rowspan="1" colspan="1">0.43492520.4556044</td>
                          <td align="right" rowspan="1" colspan="1">0.31959320.3918639</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NDRG1</td>
                          <td align="left" rowspan="1" colspan="1">N-myc downstream regulated gene 1 (Ndrg1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008681.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4352534</td>
                          <td align="right" rowspan="1" colspan="1">0.3870171</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MS4A6D</td>
                          <td align="left" rowspan="1" colspan="1">membrane-spanning 4-domains, subfamily A, member 6D (Ms4a6d), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_026835.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4373044</td>
                          <td align="right" rowspan="1" colspan="1">0.0358791</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ALOX5AP</td>
                          <td align="left" rowspan="1" colspan="1">arachidonate 5-lipoxygenase activating protein (Alox5ap), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009663.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4387523</td>
                          <td align="right" rowspan="1" colspan="1">0.0317102</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AG</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ag (Hist1h2ag), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178186.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4395184</td>
                          <td align="right" rowspan="1" colspan="1">0.2645484</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1300002F13RIK</td>
                          <td align="left" rowspan="1" colspan="1">ERBB receptor feedback inhibitor 1 (Errfi1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_133753.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4395548</td>
                          <td align="right" rowspan="1" colspan="1">0.2132049</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EVI2A</td>
                          <td align="left" rowspan="1" colspan="1">ecotropic viral integration site 2a (Evi2a), transcript variant 2, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010161.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4402088</td>
                          <td align="right" rowspan="1" colspan="1">0.1280774</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CXCL4</td>
                          <td align="left" rowspan="1" colspan="1">chemokine (C-X-C motif) ligand 4 (Cxcl4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_019932.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4419611</td>
                          <td align="right" rowspan="1" colspan="1">0.180652</td>
                          <td align="left" rowspan="1" colspan="1">CH</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1190002H23RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 1190002H23 gene (1190002H23Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_025427.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4430251</td>
                          <td align="right" rowspan="1" colspan="1">0.3481645</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ENO1</td>
                          <td align="left" rowspan="1" colspan="1">enolase 1, alpha non-neuron (Eno1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_023119.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4461543</td>
                          <td align="right" rowspan="1" colspan="1">0.4872021</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LYZ</td>
                          <td align="left" rowspan="1" colspan="1">lysozyme 1 (Lyz1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013590.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4473266</td>
                          <td align="right" rowspan="1" colspan="1">0.3851333</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CD52</td>
                          <td align="left" rowspan="1" colspan="1">CD52 antigen (Cd52), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013706.1</td>
                          <td align="right" rowspan="1" colspan="1">0.44963</td>
                          <td align="right" rowspan="1" colspan="1">0.0749331</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NDRL</td>
                          <td align="left" rowspan="1" colspan="1">N-myc downstream gene 1 (Ndrl), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="right" rowspan="1" colspan="1">0.4504366</td>
                          <td align="right" rowspan="1" colspan="1">0.4056498</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CYP7B1</td>
                          <td align="left" rowspan="1" colspan="1">cytochrome P450, family 7, subfamily b, polypeptide 1 (Cyp7b1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007825.3</td>
                          <td align="right" rowspan="1" colspan="1">0.450876</td>
                          <td align="right" rowspan="1" colspan="1">0.1997939</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PIRA4</td>
                          <td align="left" rowspan="1" colspan="1">paired-Ig-like receptor A4 (Pira4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011091.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4527747</td>
                          <td align="right" rowspan="1" colspan="1">0.0263051</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RARRES2</td>
                          <td align="left" rowspan="1" colspan="1">retinoic acid receptor responder (tazarotene induced) 2 (Rarres2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_027852.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4537163</td>
                          <td align="right" rowspan="1" colspan="1">0.3671236</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CD14</td>
                          <td align="left" rowspan="1" colspan="1">CD14 antigen (Cd14), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009841.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4582975</td>
                          <td align="right" rowspan="1" colspan="1">0.1117494</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ALDH3B1</td>
                          <td align="left" rowspan="1" colspan="1">aldehyde dehydrogenase 3 family, member B1 (Aldh3b1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_026316.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4627661</td>
                          <td align="right" rowspan="1" colspan="1">0.3188771</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">KCNAB2</td>
                          <td align="left" rowspan="1" colspan="1">potassium voltage-gated channel, shaker-related subfamily, beta member 2 (Kcnab2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010598.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4659567</td>
                          <td align="right" rowspan="1" colspan="1">0.1179869</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C1QG</td>
                          <td align="left" rowspan="1" colspan="1">complement component 1, q subcomponent, C chain (C1qc), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007574.2</td>
                          <td align="right" rowspan="1" colspan="1">0.468035</td>
                          <td align="right" rowspan="1" colspan="1">0.3163972</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GALNT9</td>
                          <td align="left" rowspan="1" colspan="1">UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (Galnt9), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_198306.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4683551</td>
                          <td align="right" rowspan="1" colspan="1">0.3906375</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ADD3</td>
                          <td align="left" rowspan="1" colspan="1">adducin 3 (gamma) (Add3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013758.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4687887</td>
                          <td align="right" rowspan="1" colspan="1">0.306828</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ZFP36L1</td>
                          <td align="left" rowspan="1" colspan="1">zinc finger protein 36, C3H type-like 1 (Zfp36l1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007564.4</td>
                          <td align="right" rowspan="1" colspan="1">0.4703194</td>
                          <td align="right" rowspan="1" colspan="1">0.2280471</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HEMP1</td>
                          <td align="left" rowspan="1" colspan="1">NCK associated protein 1 like (Nckap1l), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_153505.4</td>
                          <td align="right" rowspan="1" colspan="1">0.4709411</td>
                          <td align="right" rowspan="1" colspan="1">0.0826084</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2810046M22RIK</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">NM_026621.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4778584</td>
                          <td align="right" rowspan="1" colspan="1">0.4976117</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LGMN</td>
                          <td align="left" rowspan="1" colspan="1">legumain (Lgmn), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011175.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4770529</td>
                          <td align="right" rowspan="1" colspan="1">0.2286424</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TXNIP</td>
                          <td align="left" rowspan="1" colspan="1">thioredoxin interacting protein (Txnip), transcript variant 1, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001009935.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4827267</td>
                          <td align="right" rowspan="1" colspan="1">0.3327381</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EHD4</td>
                          <td align="left" rowspan="1" colspan="1">EH-domain containing 4 (Ehd4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_133838.4</td>
                          <td align="right" rowspan="1" colspan="1">0.483588</td>
                          <td align="right" rowspan="1" colspan="1">0.3327381</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EMR1</td>
                          <td align="left" rowspan="1" colspan="1">EGF-like module containing, mucin-like, hormone receptor-like sequence 1 (Emr1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010130.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4839607</td>
                          <td align="right" rowspan="1" colspan="1">0.1299728</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ARHGAP20</td>
                          <td align="left" rowspan="1" colspan="1">Rho GTPase activating protein 20 (Arhgap20), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175535.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4859805</td>
                          <td align="right" rowspan="1" colspan="1">0.4102931</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PTX3</td>
                          <td align="left" rowspan="1" colspan="1">pentaxin related gene (Ptx3) mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_008987.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4867727</td>
                          <td align="right" rowspan="1" colspan="1">0.1136763</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NCF4</td>
                          <td align="left" rowspan="1" colspan="1">neutrophil cytosolic factor 4 (Ncf4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008677.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4881307</td>
                          <td align="right" rowspan="1" colspan="1">0.1080301</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PFC</td>
                          <td align="left" rowspan="1" colspan="1">complement factor properdin (Cfp), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008823.3</td>
                          <td align="right" rowspan="1" colspan="1">0.488737</td>
                          <td align="right" rowspan="1" colspan="1">0.0720321</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SMARCA1</td>
                          <td align="left" rowspan="1" colspan="1">SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 (Smarca1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_053123.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4911543</td>
                          <td align="right" rowspan="1" colspan="1">0.3176144</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">FCER1G</td>
                          <td align="left" rowspan="1" colspan="1">Fc receptor IgE high affinity 1 gamma polypeptide (Fcerg) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010185.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4915371</td>
                          <td align="right" rowspan="1" colspan="1">0.0163625</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CENPA</td>
                          <td align="left" rowspan="1" colspan="1">centromere protein A (Cenpa), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007681.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4943203</td>
                          <td align="right" rowspan="1" colspan="1">0.0808812</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1200002N14RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 1200002N14 gene (1200002N14Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_027878.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4949315</td>
                          <td align="right" rowspan="1" colspan="1">0.207954</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TK1</td>
                          <td align="left" rowspan="1" colspan="1">thymidine kinase 1 (Tk1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009387.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4950169</td>
                          <td align="right" rowspan="1" colspan="1">0.1742371</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ALDOA</td>
                          <td align="left" rowspan="1" colspan="1">aldolase A, fructose-bisphosphate (Aldoa), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007438.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4959253</td>
                          <td align="right" rowspan="1" colspan="1">0.4941576</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SLPI</td>
                          <td align="left" rowspan="1" colspan="1">secretory leukocyte peptidase inhibitor (Slpi), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011414.2</td>
                          <td align="right" rowspan="1" colspan="1">0.4988716</td>
                          <td align="right" rowspan="1" colspan="1">0.2429238</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>Genes (115) downregulated by both microgravity and <italic>Pthrp</italic> ablation. All fold changes &lt; 0.5. All p values &lt; 0.05. Multiple entries for a gene indicate multiple probes. C: Clustering: A: apoptosis/survival, B: bone metabolism and bone morphogenic proteins, CC: cell cycle, CH: chemokines, E: extracellular matrix, H: histone, I: Insulin-like growth factor, PD: Platelet-derived growth factor, T: tumor growth factor, W: Wnt.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Because the PTHrP<sub>1-36</sub> anabolic agent was observed to compensate for weightlessness and reverse the effects of microgravity exposure in TOs (Figs <xref ref-type="fig" rid="pone.0160034.g001">1</xref>, <xref ref-type="fig" rid="pone.0160034.g002">2</xref> and <xref ref-type="fig" rid="pone.0160034.g003">3</xref>), microarray analysis was conducted on <italic>Pthrp</italic><sup><italic>+/+</italic></sup> TOs at 0<italic>g</italic> treated intermittently with 10<sup>-8</sup>M PTHrP<sub>1-36</sub> for 6 days. The expression levels of 102 genes were upregulated and 61 downregulated (total 163, fold change &gt;1.5 or &lt;0.65, <italic>p</italic> value&lt; 0.05, complete list in <xref ref-type="supplementary-material" rid="pone.0160034.s005">S4A and S4B Table</xref>). Although the treatment peptide corresponds to only 36 amino acids from the N-terminus of PTHrP and not the whole sequence, we expect reversal of some effects induced by microgravity and/or <italic>Pthrp</italic> ablation. Accordingly, 27 of the 0<italic>g</italic>-upregulated genes (45.7%), and 34 of the ablation-upregulated genes (12.5%) were downregulated by PTHrP<sub>1-36</sub> treatment. Of those, 24 genes were common to all three conditions (<xref ref-type="fig" rid="pone.0160034.g005">Fig 5C</xref>, listed in <xref rid="pone.0160034.t003" ref-type="table">Table 3</xref>). 53 of the 0<italic>g</italic>-downregulated (41%) and 95 of the ablation-downregulated genes (19.2%) were upregulated by PTHrP<sub>1-36</sub> treatment. Of those, 50 genes were common to all three conditions (<xref ref-type="fig" rid="pone.0160034.g005">Fig 5D</xref>, listed in <xref rid="pone.0160034.t004" ref-type="table">Table 4</xref>). Clustering analysis revealed the same functional gene categories as above. None of the significantly-affected genes presented a contradictory direction change in expression level between PTHrP<sub>1-36</sub> treatment and <italic>Pthrp</italic> ablation or microgravity treatment (<xref ref-type="supplementary-material" rid="pone.0160034.s001">S1 Fig</xref>).</p>
                <table-wrap id="pone.0160034.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Genes (24) upregulated by both <italic>Pthrp</italic> ablation and microgravity and downregulated by PTHrP<sub>1-36</sub> treatment.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0160034.t003g" xlink:href="pone.0160034.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Target ID</th>
                          <th align="left" rowspan="1" colspan="1">Definition (all probes: <italic>Mus musculus</italic>)</th>
                          <th align="left" rowspan="1" colspan="1">RefSeqID</th>
                          <th align="left" rowspan="1" colspan="1">Fold change PTHrP 1–36 treatment</th>
                          <th align="left" rowspan="1" colspan="1">C</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">AQP5</td>
                          <td align="left" rowspan="1" colspan="1">aquaporin 5 (Aqp5), mRNA.PREDICTED: similar to aquaporin 5 (LOC100046616), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009701.4XM_001476512.1</td>
                          <td align="right" rowspan="1" colspan="1">0.37050890.4987479</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TNFRSF11B</td>
                          <td align="left" rowspan="1" colspan="1">tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (Tnfrsf11b), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008764.3</td>
                          <td align="right" rowspan="1" colspan="1">0.4687011</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HSPB1</td>
                          <td align="left" rowspan="1" colspan="1">heat shock protein 1 (Hspb1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013560.1</td>
                          <td align="right" rowspan="1" colspan="1">0.4871401</td>
                          <td align="left" rowspan="1" colspan="1">HS</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MRPPLF3</td>
                          <td align="left" rowspan="1" colspan="1">prolactin family 2, subfamily c, member 4 (Prl2c4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011954.2</td>
                          <td align="right" rowspan="1" colspan="1">0.5052176</td>
                          <td align="left" rowspan="1" colspan="1">P</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NKD2</td>
                          <td align="left" rowspan="1" colspan="1">naked cuticle 2 homolog (Drosophila) (Nkd2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_028186.3</td>
                          <td align="right" rowspan="1" colspan="1">0.5150308</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PLF2</td>
                          <td align="left" rowspan="1" colspan="1">prolactin family 2, subfamily c, member 3 (Prl2c3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011118.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5191368</td>
                          <td align="left" rowspan="1" colspan="1">P</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">BDNF</td>
                          <td align="left" rowspan="1" colspan="1">brain derived neurotrophic factor (Bdnf), transcript variant 3, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001048141.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5334656</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TIMP3</td>
                          <td align="left" rowspan="1" colspan="1">tissue inhibitor of metalloproteinase 3 (Timp3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011595.2NM_011595.2</td>
                          <td align="right" rowspan="1" colspan="1">0.53376130.6267908</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CRYAB</td>
                          <td align="left" rowspan="1" colspan="1">crystallin, alpha B (Cryab), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009964.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5387105</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ASS1</td>
                          <td align="left" rowspan="1" colspan="1">argininosuccinate synthetase 1 (Ass1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007494.3</td>
                          <td align="right" rowspan="1" colspan="1">0.5595178</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ESD</td>
                          <td align="left" rowspan="1" colspan="1">esterase D/formylglutathione hydrolase (Esd), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_016903.2</td>
                          <td align="right" rowspan="1" colspan="1">0.5693265</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">INHBA</td>
                          <td align="left" rowspan="1" colspan="1">inhibin beta-A (Inhba), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008380.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5792015</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CD44</td>
                          <td align="left" rowspan="1" colspan="1">CD44 antigen (Cd44), transcript variant 2, mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_001039150.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5834</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GREM1</td>
                          <td align="left" rowspan="1" colspan="1">gremlin1 (Grem1) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011824.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5978743</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GDF15</td>
                          <td align="left" rowspan="1" colspan="1">growth differentiation factor 15 (Gdf15), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_011819.1</td>
                          <td align="right" rowspan="1" colspan="1">0.5985932</td>
                          <td align="left" rowspan="1" colspan="1">T</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MUSTN1</td>
                          <td align="left" rowspan="1" colspan="1">musculoskeletal, embryonic nuclear protein 1 (Mustn1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_181390.1</td>
                          <td align="right" rowspan="1" colspan="1">0.6015734</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MDM2</td>
                          <td align="left" rowspan="1" colspan="1">transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010786.2</td>
                          <td align="right" rowspan="1" colspan="1">0.6034403</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">KCTD10</td>
                          <td align="left" rowspan="1" colspan="1">potassium channel tetramerisation domain containing 10 (Kctd10), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_026145.3</td>
                          <td align="right" rowspan="1" colspan="1">0.61132</td>
                          <td align="left" rowspan="1" colspan="1">IC</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EEF1A2</td>
                          <td align="left" rowspan="1" colspan="1">eukaryotic translation elongation factor 1 alpha 2 (Eef1a2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007906.2</td>
                          <td align="right" rowspan="1" colspan="1">0.6231256</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">WHRN</td>
                          <td align="left" rowspan="1" colspan="1">whirlin (Whrn), transcript variant 3, mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_001008792.1</td>
                          <td align="right" rowspan="1" colspan="1">0.6237</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EPHX1</td>
                          <td align="left" rowspan="1" colspan="1">epoxide hydrolase 1, microsomal (Ephx1), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_010145.2</td>
                          <td align="right" rowspan="1" colspan="1">0.6255</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H4H</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H4h (Hist1h4h), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_153173.2</td>
                          <td align="right" rowspan="1" colspan="1">0.635</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">STMN2</td>
                          <td align="left" rowspan="1" colspan="1">stathmin-like 2 (Stmn2), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_025285.2</td>
                          <td align="right" rowspan="1" colspan="1">0.645</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SCX</td>
                          <td align="left" rowspan="1" colspan="1">scleraxis (Scx), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_198885.2</td>
                          <td align="right" rowspan="1" colspan="1">0.6553575</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>All -fold changes &lt; 0.66, all p values &lt; 0.05. Multiple entries for a gene indicate multiple probes. C: Clustering: A: apoptosis/survival, B: bone metabolism and bone morphogenic proteins, E: extracellular matrix, H: histone, HS: heat shock, IC: ion channel, P: prolactin, T: tumor growth factor, W: Wnt.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="pone.0160034.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0160034.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Genes (50) downregulated by both <italic>Pthrp</italic> ablation and microgravity and upregulated by PTHrP<sub>1-36</sub> treatment.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0160034.t004g" xlink:href="pone.0160034.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Target ID</th>
                          <th align="left" rowspan="1" colspan="1">Definition (all probes: <italic>Mus musculus</italic>)</th>
                          <th align="left" rowspan="1" colspan="1">RefSeqID</th>
                          <th align="left" rowspan="1" colspan="1">Fold change PTHrP 1–36 treatment</th>
                          <th align="left" rowspan="1" colspan="1">C</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RBM3</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: similar to RNA binding motif protein 3 (LOC100043257), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">XM_001480197.1</td>
                          <td align="right" rowspan="1" colspan="1">3.316729</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AD</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ad (Hist1h2ad), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178188.3</td>
                          <td align="right" rowspan="1" colspan="1">3.070246</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AH</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ah (Hist1h2ah), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175659.1</td>
                          <td align="right" rowspan="1" colspan="1">2.644405</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AN</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2an (Hist1h2an), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178184.1</td>
                          <td align="right" rowspan="1" colspan="1">2.629741</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AK</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ak (Hist1h2ak), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178183.1</td>
                          <td align="right" rowspan="1" colspan="1">2.619065</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PTN</td>
                          <td align="left" rowspan="1" colspan="1">pleiotrophin (Ptn), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008973.2</td>
                          <td align="right" rowspan="1" colspan="1">2.610166</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AF</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2af (Hist1h2af), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_175661.1</td>
                          <td align="right" rowspan="1" colspan="1">2.590586</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AO</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ao (Hist1h2ao), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178185.1</td>
                          <td align="right" rowspan="1" colspan="1">2.363633</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2310061N23RIK</td>
                          <td align="left" rowspan="1" colspan="1">interferon, alpha-inducible protein 27 (Ifi27), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_029803.1</td>
                          <td align="right" rowspan="1" colspan="1">2.240007</td>
                          <td align="left" rowspan="1" colspan="1">A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CENPA</td>
                          <td align="left" rowspan="1" colspan="1">centromere protein A (Cenpa), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007681.2</td>
                          <td align="right" rowspan="1" colspan="1">2.217246</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">HIST1H2AG</td>
                          <td align="left" rowspan="1" colspan="1">histone cluster 1, H2ag (Hist1h2ag), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178186.2</td>
                          <td align="right" rowspan="1" colspan="1">2.186001</td>
                          <td align="left" rowspan="1" colspan="1">H</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LUM</td>
                          <td align="left" rowspan="1" colspan="1">lumican (Lum), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008524.1</td>
                          <td align="right" rowspan="1" colspan="1">2.127828</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ITM2A</td>
                          <td align="left" rowspan="1" colspan="1">integral membrane protein 2A (Itm2a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008409.2</td>
                          <td align="right" rowspan="1" colspan="1">2.072151</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">IGFBP5</td>
                          <td align="left" rowspan="1" colspan="1">insulin-like growth factor binding protein 5 (Igfbp5), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010518.2</td>
                          <td align="right" rowspan="1" colspan="1">2.068563</td>
                          <td align="left" rowspan="1" colspan="1">I</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DCN</td>
                          <td align="left" rowspan="1" colspan="1">decorin (Dcn), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007833.4</td>
                          <td align="right" rowspan="1" colspan="1">2.0663121.731693</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1500015O10RIK</td>
                          <td align="left" rowspan="1" colspan="1">RIKEN cDNA 1500015O10 gene (1500015O10Rik), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_024283.2</td>
                          <td align="right" rowspan="1" colspan="1">1.860714</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">MFAP2</td>
                          <td align="left" rowspan="1" colspan="1">microfibrillar-associated protein 2 (Mfap2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008546.2</td>
                          <td align="right" rowspan="1" colspan="1">1.8432941.5754411.501827</td>
                          <td align="left" rowspan="1" colspan="1">B</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TK1</td>
                          <td align="left" rowspan="1" colspan="1">thymidine kinase 1 (Tk1), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_009387.1</td>
                          <td align="right" rowspan="1" colspan="1">1.8403</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ALOX5AP</td>
                          <td align="left" rowspan="1" colspan="1">arachidonate 5-lipoxygenase activating protein (Alox5ap), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_009663.1</td>
                          <td align="right" rowspan="1" colspan="1">1.8329</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CDKN1C</td>
                          <td align="left" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor 1C (P57) (Cdkn1c), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009876.3</td>
                          <td align="right" rowspan="1" colspan="1">1.797543</td>
                          <td align="left" rowspan="1" colspan="1">CC</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GPR23</td>
                          <td align="left" rowspan="1" colspan="1">G protein-coupled receptor 23 (Gpr23), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_175271.2</td>
                          <td align="right" rowspan="1" colspan="1">1.7145</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CD52</td>
                          <td align="left" rowspan="1" colspan="1">CD52 antigen (Cd52), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013706.1</td>
                          <td align="right" rowspan="1" colspan="1">1.688404</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C1QA</td>
                          <td align="left" rowspan="1" colspan="1">complement component 1, q subcomponent, alpha polypeptide (C1qa), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007572.2</td>
                          <td align="right" rowspan="1" colspan="1">1.685787</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CTSC</td>
                          <td align="left" rowspan="1" colspan="1">cathepsin C (Ctsc), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009982.2</td>
                          <td align="right" rowspan="1" colspan="1">1.68393</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ALDH3B1</td>
                          <td align="left" rowspan="1" colspan="1">aldehyde dehydrogenase 3 family, member B1 (Aldh3b1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_026316.2</td>
                          <td align="right" rowspan="1" colspan="1">1.678022</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TGFBI</td>
                          <td align="left" rowspan="1" colspan="1">transforming growth factor, beta induced (Tgfbi), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009369.1</td>
                          <td align="right" rowspan="1" colspan="1">1.664148</td>
                          <td align="left" rowspan="1" colspan="1">T</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">FMO1</td>
                          <td align="left" rowspan="1" colspan="1">flavin containing monooxygenase 1 (Fmo1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010231.2</td>
                          <td align="right" rowspan="1" colspan="1">1.657767</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">IGF2</td>
                          <td align="left" rowspan="1" colspan="1">insulin-like growth factor 2 (Igf2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010514.2</td>
                          <td align="right" rowspan="1" colspan="1">1.656335</td>
                          <td align="left" rowspan="1" colspan="1">I</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CYP7B1</td>
                          <td align="left" rowspan="1" colspan="1">cytochrome P450, family 7, subfamily b, polypeptide 1 (Cyp7b1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_007825.3</td>
                          <td align="right" rowspan="1" colspan="1">1.652679</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CXCL12</td>
                          <td align="left" rowspan="1" colspan="1">chemokine (C-X-C motif) ligand 12 (Cxcl12) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_013655.2</td>
                          <td align="right" rowspan="1" colspan="1">1.637518</td>
                          <td align="left" rowspan="1" colspan="1">CH</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LDB2</td>
                          <td align="left" rowspan="1" colspan="1">LIM domain-binding 2 (Ldb2) mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010698.2</td>
                          <td align="right" rowspan="1" colspan="1">1.634978</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CORO1A</td>
                          <td align="left" rowspan="1" colspan="1">coronin, actin binding protein 1A (Coro1a), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009898.2</td>
                          <td align="right" rowspan="1" colspan="1">1.6294451.620518</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EMR1</td>
                          <td align="left" rowspan="1" colspan="1">EGF-like module containing, mucin-like, hormone receptor-like sequence 1 (Emr1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010130.3</td>
                          <td align="right" rowspan="1" colspan="1">1.626247</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">KNG1</td>
                          <td align="left" rowspan="1" colspan="1">kininogen 1 (Kng1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_023125.2</td>
                          <td align="right" rowspan="1" colspan="1">1.5999</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">OLFML1</td>
                          <td align="left" rowspan="1" colspan="1">olfactomedin-like 1 (Olfml1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_172907.2</td>
                          <td align="right" rowspan="1" colspan="1">1.599738</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">AOC3</td>
                          <td align="left" rowspan="1" colspan="1">amine oxidase, copper containing 3 (Aoc3), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009675.1</td>
                          <td align="right" rowspan="1" colspan="1">1.598282</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">GMFG</td>
                          <td align="left" rowspan="1" colspan="1">glia maturation factor, gamma (Gmfg), transcript variant 1, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_022024.2</td>
                          <td align="right" rowspan="1" colspan="1">1.5965611.532455</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NCF4</td>
                          <td align="left" rowspan="1" colspan="1">neutrophil cytosolic factor 4 (Ncf4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008677.1</td>
                          <td align="right" rowspan="1" colspan="1">1.593552</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SFRP2</td>
                          <td align="left" rowspan="1" colspan="1">secreted frizzled-related protein 2 (Sfrp2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009144.1</td>
                          <td align="right" rowspan="1" colspan="1">1.589225</td>
                          <td align="left" rowspan="1" colspan="1">W</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SMARCA1</td>
                          <td align="left" rowspan="1" colspan="1">SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 (Smarca1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_053123.3</td>
                          <td align="right" rowspan="1" colspan="1">1.5706</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SIRPB1</td>
                          <td align="left" rowspan="1" colspan="1">signal-regulatory protein beta 1 (Sirpb1), transcript variant 3, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_001002898.1</td>
                          <td align="right" rowspan="1" colspan="1">1.559451</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">RASSF4</td>
                          <td align="left" rowspan="1" colspan="1">Ras association (RalGDS/AF-6) domain family member 4 (Rassf4), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_178045.3</td>
                          <td align="right" rowspan="1" colspan="1">1.558789</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">KCNAB2</td>
                          <td align="left" rowspan="1" colspan="1">potassium voltage-gated channel, shaker-related subfamily, beta member 2 (Kcnab2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010598.2</td>
                          <td align="right" rowspan="1" colspan="1">1.556591</td>
                          <td align="left" rowspan="1" colspan="1">IC</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">LSP1</td>
                          <td align="left" rowspan="1" colspan="1">PREDICTED: predicted gene, ENSMUSG00000043795 (ENSMUG00000043795), mRNA</td>
                          <td align="left" rowspan="1" colspan="1">XM_001480835.1</td>
                          <td align="right" rowspan="1" colspan="1">1.5468</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">COL3A1</td>
                          <td align="left" rowspan="1" colspan="1">collagen, type III, alpha 1 (Col3a1), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009930.1</td>
                          <td align="right" rowspan="1" colspan="1">1.531741</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SRPX</td>
                          <td align="left" rowspan="1" colspan="1">sushi-repeat-containing protein (Srpx), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_016911.4</td>
                          <td align="right" rowspan="1" colspan="1">1.522525</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">DAB2</td>
                          <td align="left" rowspan="1" colspan="1">disabled 2 mitogen-responsive phosphoprotein (Dab2) mRNA</td>
                          <td align="left" rowspan="1" colspan="1">NM_023118.1</td>
                          <td align="right" rowspan="1" colspan="1">1.519832</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">EVI2A</td>
                          <td align="left" rowspan="1" colspan="1">ecotropic viral integration site 2a (Evi2a), transcript variant 2, mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_010161.3</td>
                          <td align="right" rowspan="1" colspan="1">1.517936</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">NID2</td>
                          <td align="left" rowspan="1" colspan="1">nidogen 2 (Nid2), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_008695.2</td>
                          <td align="right" rowspan="1" colspan="1">1.506611</td>
                          <td align="left" rowspan="1" colspan="1">E</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">C1QB</td>
                          <td align="left" rowspan="1" colspan="1">complement component 1, q subcomponent, beta polypeptide (C1qb), mRNA.</td>
                          <td align="left" rowspan="1" colspan="1">NM_009777.2</td>
                          <td align="right" rowspan="1" colspan="1">1.503228</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p>All -fold changes &gt; 1.5, all p values &lt; 0.05. C: Clustering: A: apoptosis/survival, B: bone metabolism and bone morphogenic proteins, CC: cell cycle, CH: chemokines, E: extracellular matrix, H: histone, I: Insulin-like growth factor, IC: ion channel, T: tumor growth factor, W: Wnt.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec020">
              <title>Discussion</title>
              <p>Exposure to Space microgravity causes an important and rapid decrease in the BMD of astronauts’ weight-bearing bones similar to that observed in disuse osteoporosis on Earth [<xref rid="pone.0160034.ref045" ref-type="bibr">45</xref>]. Exercise in weightless conditions does not effectively counter spine and hip bone loss, and a better understanding of bone formation/resorption uncoupling mechanisms under these conditions is needed in order to provide effective countermeasures useful to flight personnel as well as to patients suffering from disuse-induced osteoporosis on Earth. Microgravity has been reported to reduce the expression of PTHrP in lung and bone cells, leading to speculation that this molecule can act as a gravisensor [<xref rid="pone.0160034.ref033" ref-type="bibr">33</xref>]. In view of the fact that bone loss appears to result in significant part from osteoblast dysfunction, we investigated the mechanistic implications of PTHrP metabolism in 0<italic>g</italic>-induced skeletal disorders using mouse wild-type trabecular osteoblasts (<italic>Pthrp</italic><sup><italic>+/+</italic></sup>) which mimic astronauts’ TOs at the start of their mission. Comparison of viability of the wild-type cells with <italic>Pthrp</italic><sup><italic>+/-</italic></sup> and <sup>-/-</sup> TOs confirmed the involvement of PTHrP in resistance to microgravity: a 6-day exposure to microgravity (actual and simulated) significantly decreased viability of <italic>Pthrp</italic><sup><italic>-/-</italic></sup> trabecular osteoblasts while <italic>Pthrp</italic><sup><italic>+/+</italic></sup> cells appeared unaffected. An allelic dose-effect for PTHrP expression was even observed using heterozygous <italic>Pthrp</italic><sup><italic>+/-</italic></sup> TOs in simulated 0<italic>g</italic>. Although <italic>Pthrp</italic><sup><italic>+/+</italic></sup> cells maintained viability after 6 days at 0<italic>g</italic>, a crucial observation made during exposure of TOs to longer periods of simulated microgravity revealed that the astronaut-mimicking <italic>Pthrp</italic><sup><italic>+/+</italic></sup> TOs start to lose viability at 2 weeks, suggesting early metabolic changes in the wild-type cells at 0<italic>g</italic>. Importantly, this sharp decline in viability could be countered by treatment with 10<sup>-8</sup>M PTHrP<sub>1-36</sub> peptide which, when administered intermittently (in a pulsatile manner), has anabolic properties, in contrast with a continuous treatment which causes downregulation of osteogenic genes [<xref rid="pone.0160034.ref036" ref-type="bibr">36</xref>]. These observations confirmed the role of PTHrP in cell survival in microgravity in trabecular osteoblasts. In the present study, calvarial osteoblasts appeared much less sensitive to 0<italic>g</italic> conditions than trabecular osteoblasts, an observation which agrees with those made in human 6° head-down bedrest prolonged tests (which effectively mimic weightlessness) where weight-bearing bones incur substantial skeletal loss but cranium bones in fact appear to gain bone mass [<xref rid="pone.0160034.ref046" ref-type="bibr">46</xref>].</p>
              <p>The mechanisms by which PTHrP counters the signal of absent gravity were investigated through expression array analyses revealing that radical changes were already occurring in <italic>Pthrp</italic><sup><italic>+/+</italic></sup> TOs after 6 days in microgravity. Strikingly, the genes affected by 0<italic>g</italic> present an 87% overlap with genes affected by <italic>Pthrp</italic> ablation (comparison of <italic>Pthrp</italic><sup><italic>+/+</italic></sup> and <italic>Pthrp</italic><sup><italic>-/-</italic></sup> TOs at 1<italic>g</italic>), and all changes proceed in the same direction for ablation and 0<italic>g</italic> exposure. This observation indicates that microgravity-induced metabolic changes in wild-type trabecular osteoblasts proceed mostly through PTHrP-controlled genes, affirming a prominent role of PTHrP in cell survival under microgravity. Among the most up- or downregulated genes common to 0<italic>g</italic> and <italic>Pthrp</italic> ablation are genes encoding members of the prolactin family, several genes involved in bone growth including Wnt signaling and insulin-like growth factor (IGF) signaling, genes encoding extracellular matrix (ECM)-related proteins and involved in BMP metabolism and, in mineralization, heat-shock proteins, chemokines, and genes encoding apoptosis/survival, cell cycle control as well as histones. A comparison of our microarray results with expression changes in wild-type mouse 2T3 pre-osteoblasts attached to growth container surface and exposed to simulated 0g for 3 days [<xref rid="pone.0160034.ref047" ref-type="bibr">47</xref>] confirms the loss of bone growth, mineralization, bone morphogenic and extra-cellular matrix proteins upon exposure to simulated microgravity by similar changes in expression of numerous common genes at 0g: osteoprotegerin, RAMP 2, lumican, decorin and various collagen proteins. Several cell signaling molecules are also similarly affected by microgravity in both studies: PDGFRα, IGF2, SFRP2, and members of the TNF and Fos family. The Wnt/βcatenin pathway is essential for bone formation in response to mechanical loading [<xref rid="pone.0160034.ref048" ref-type="bibr">48</xref>], and in our study, expression of mechanosensitive genes such as SFRP1 and 2 which regulate the Wnt pathway [<xref rid="pone.0160034.ref049" ref-type="bibr">49</xref>] was very strongly inhibited by exposure to 0g. This implicates the PTHrP pathway in this mechansensitive pathway in microgravity conditions, and agrees with results of Maycas <italic>et al</italic> [<xref rid="pone.0160034.ref050" ref-type="bibr">50</xref>] who report the involvement of PTH1R as a mechanosensor in osteocyte survival and Chen et al [<xref rid="pone.0160034.ref051" ref-type="bibr">51</xref>] who suggest PTHrP as a candidate mediator of the anabolic effects of mechanical force on bone.</p>
              <p>Intermittent treatment with PTHrP<sub>1-36</sub> of TOs not only reversed loss of viability (in short and long 0<italic>g</italic> exposures) but reversed expression changes in a significant proportion of the genes affected by microgravity. PTHrP<sub>1-36</sub> also reversed many, but a lesser number, of the changes in gene expression modified by <italic>Pthrp</italic> ablation. In that respect, it must be noted that PTHrP<sub>1-36</sub> will impact genes controlled by the N-terminus of PTHrP, and likely not genes controlled by the protein’s mid-region and C-terminus. Furthermore, reversal responses are likely to be dependent on PTHrP<sub>1-36</sub> concentration, and a dose-response curve would need to be examined for its influence on genes not affected here which might be modified by higher concentrations of PTHrP<sub>1-36</sub>.</p>
              <p>Of particular interest are the genes whose expression change in 0<italic>g</italic> was reversed by intermittent PTHrP<sub>1-36</sub> treatment as their activity is clearly linked to the maintenance of viability obtained in wild-type TOs treated during long periods at 0<italic>g</italic>. The 74 genes (24 + 50 from central intersects in <xref ref-type="fig" rid="pone.0160034.g005">Fig 5C and 5D</xref>, common to ablation and 0<italic>g</italic> and reversed by PTHrP<sub>1-36</sub>) belong to similar clustering categories as above. Among the reversals caused by treatment, some strong candidates for microgravity-induced osteoporotic involvement appear. Two genes (<italic>Mrpplf3</italic> and <italic>Plf2</italic>) that belong to the prolactin family were among the most highly-upregulated. Prolactins are hormones secreted by the pituitary gland and some extra-pituitary tissues. Mitogen-regulated protein/proliferin (MRP/PLF) proteins are members of the prolactin gene family involved in developmental processes. Prolactins have pleiotrophic actions in lactation and many other biological functions, and their expression is regulated by PTHrP [<xref rid="pone.0160034.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0160034.ref053" ref-type="bibr">53</xref>]. Exposure of pregnant rats to prolactins causes reduced ossification in pups [<xref rid="pone.0160034.ref054" ref-type="bibr">54</xref>], and abnormally high prolactin expression encountered in human conditions such as hyperprolactinemic hypogonadism, extended lactation, or as a consequence of the use of some anti-psychotic drugs, is associated with acute skeletal loss [<xref rid="pone.0160034.ref055" ref-type="bibr">55</xref>–<xref rid="pone.0160034.ref057" ref-type="bibr">57</xref>]. Our results indicate that exposure to 0<italic>g</italic> strikingly (by 12-fold) upregulates expression of prolactin genes <italic>Mrpplf3</italic> and <italic>Plf2</italic>, with highly-efficient reversal by PTHrP<sub>1-36</sub>. Our observations agree with reports that Spaceflight increases prolactin levels in rats [<xref rid="pone.0160034.ref058" ref-type="bibr">58</xref>], and that exposure of healthy male volunteers to head-down bed rest causes significant elevation of prolactin levels [<xref rid="pone.0160034.ref059" ref-type="bibr">59</xref>]. Our results demonstrate expression of prolactin genes in osteoblastic cells and implicate their products in a major bone loss event that is PTHrP-controlled and unrelated to lactation.</p>
              <p>The most highly-downregulated gene by both 0<italic>g</italic> and <italic>Pthrp</italic> ablation with reversal by PTHrP<sub>1-36</sub> is <italic>Rbm3</italic> which encodes RNA-binding motif protein 3, an inhibitor of apoptosis [<xref rid="pone.0160034.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0160034.ref061" ref-type="bibr">61</xref>]. Its expression is upregulated by PTHrP<sub>1-36</sub> which prevents TO death, suggesting <italic>Rbm3</italic> involvement in loss of viability and cell death observed at 0g and after ablation. Several genes encoding proteins involved in bone growth, mineralization, BMP and extracellular matrix metabolism are significantly upregulated (<italic>Tnfrsf11b</italic>, <italic>Bdnf</italic>, <italic>Timp3</italic>, <italic>Cryab</italic>, <italic>Grem1</italic>, <italic>Inhba</italic>, <italic>Mustn1</italic>, <italic>Scx</italic>) or downregulated (<italic>Ptn</italic>, <italic>Itm2a</italic>, <italic>Lum</italic>, <italic>Dcn</italic>, <italic>Mfap2</italic>, <italic>Ctsc</italic>, <italic>Col3a1</italic>, <italic>Nid2</italic>) by both 0<italic>g</italic> and <italic>Pthrp</italic> ablation. Of interest among others, the highly-downregulated <italic>Ptn</italic> gene encodes pleitrophin, an osteoblast-secreted matrix-associated heparin-binding protein which enhances osteogenic differentiation of bone marrow cells [<xref rid="pone.0160034.ref062" ref-type="bibr">62</xref>]. <italic>Tnfrsf11b</italic> which encodes osteoprotegerin, the decoy to the receptor activator of nuclear factor kappa-B ligand (RANKL), regulates bone mass by inhibiting osteoclast differentiation and activation. It was found in our study to be strongly upregulated by both microgravity and <italic>Pthrp</italic> ablation in trabecular osteoblasts but downregulated by 0<italic>g</italic> in calvarial osteoblasts [<xref rid="pone.0160034.ref063" ref-type="bibr">63</xref>], suggesting a role in TO and CO different behaviors in microgravity. Also strongly upregulated is <italic>Timp3</italic> (encoding tissue inhibitor of metalloprotease 3) which regulates ECM calcium deposition, and whose overexpression prevents osteoblast differentiation [<xref rid="pone.0160034.ref064" ref-type="bibr">64</xref>]. Gremlin overexpression is known to cause osteopenia and conditional deletion increases bone mass [<xref rid="pone.0160034.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0160034.ref066" ref-type="bibr">66</xref>], in agreement with our observation that 0g and ablation upregulate <italic>Grem1</italic>. Members of the IGF and chemokine families are downregulated by 0<italic>g</italic> and <italic>Pthrp</italic> ablation with reversal by PTHrP<sub>1-36</sub>. <italic>Igf2</italic> increases bone formation and bone apposition rates [<xref rid="pone.0160034.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0160034.ref068" ref-type="bibr">68</xref>], and <italic>Igfbp5</italic> stimulates osteoblast proliferation [<xref rid="pone.0160034.ref069" ref-type="bibr">69</xref>]. Chemokine ligand Cxcl12 expression accompanies osteoblast differentiation [<xref rid="pone.0160034.ref070" ref-type="bibr">70</xref>] and its downregulation suggests loss of osteoblast characteristics. All of the above changes point to rapid and profound modifications in trabecular osteoblast metabolism in 0<italic>g</italic> conditions.</p>
              <p>The fact that bone loss in flight personnel is reversible to a certain extent upon return to Earth [<xref rid="pone.0160034.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0160034.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0160034.ref072" ref-type="bibr">72</xref>] indicates a major difference between Space-induced secondary osteoporosis and the primary aging-associated osteoporosis which is largely irreversible in absence of pharmacologic intervention. It is also interesting to note that in genome-wide association studies, genes associated with aging-related BMD loss do not overlap with those highlighted in our study except for PTHrP [<xref rid="pone.0160034.ref073" ref-type="bibr">73</xref>], osteoprotegerin [<xref rid="pone.0160034.ref074" ref-type="bibr">74</xref>], and <italic>Ptn</italic> [<xref rid="pone.0160034.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0160034.ref076" ref-type="bibr">76</xref>] suggesting mechanistic differences in bone loss control between these two types of osteoporosis.</p>
            </sec>
            <sec sec-type="conclusions" id="sec021">
              <title>Conclusions</title>
              <p>In this study, we present <italic>in vitro</italic> evidence that naturally-expressed PTHrP in TOs has an important anti-apoptotic function in weightless conditions. Our results confirm a survival role for PTHrP in microgravity-exposed osteoblasts, and identify molecules of interest for further investigation in order to find efficient targets for prevention of bone loss due to skeletal unloading. In particular, the involvement of members of the prolactin family suggests a novel mechanistic hypothesis for transmission of the weightlessness stimulus. The role of PTHrP in maintaining low levels of prolactins may be crucial to prevent microgravity-induced osteoporosis and, by extension, disuse osteoporosis.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec022">
              <title>Supporting Information</title>
              <supplementary-material content-type="local-data" id="pone.0160034.s001">
                <label>S1 Fig</label>
                <caption>
                  <title>Matrix table (pair-wise combination) of common genes.</title>
                  <p>The 4 genes downregulated by both 0<italic>g</italic> and PTHrP<sub>1-36</sub> treatment are <italic>Fos</italic>, <italic>Zfp36</italic>, <italic>Pvrlz</italic> and <italic>JunB</italic>.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0160034.s001.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0160034.s002">
                <label>S1 Table</label>
                <caption>
                  <title>Summary of experimental conditions aboard satellite Foton M3.</title>
                  <p>Pre-programmed valves allowed 5 ml (or less) volumes to be fed through the bioreactors. Each PTHrP<sub>1-36</sub> treatment was preceded by a 1-min flush, and the 2-h treatment was followed by 2 growth medium rinses and an overnight growth medium feed.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0160034.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0160034.s003">
                <label>S2 Table</label>
                <caption>
                  <title>Complete list of wild-type trabecular osteoblast genes (total 188) whose expression is modified by exposure to 6 days of simulated microgravity (<italic>Pthrp</italic>
<sup>+/+</sup> at 1g compared to <italic>Pthrp</italic>
<sup>+/+</sup> at 0g).</title>
                  <p><bold>(A)</bold> Genes (total 59) upregulated by 0g (6 days). Fold change &gt; 2.0, p &lt; 0.05. <bold>(B)</bold> Genes (total 129) downregulated by 0g (6 days). Fold change &lt; 0.5, p value&lt; 0.05. All probes: <italic>Mus musculus</italic>.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0160034.s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0160034.s004">
                <label>S3 Table</label>
                <caption>
                  <title>Complete list of trabecular osteoblasts genes (total 763) whose expression is modified by <italic>Pthrp</italic> gene ablation (<italic>Pthrp</italic>
<sup>+/+</sup> at 1g compared to Pthrp<sup>-/-</sup> at 1g).</title>
                  <p><bold>(A)</bold> Genes (total 270) upregulated by <italic>Pthrp</italic> ablation at 1 g. Fold change &gt; 2.0, p &lt; 0.05. <bold>(B)</bold> Genes (total 493) downregulated by <italic>Pthrp</italic> ablation at 1g. Fold change &lt; 0.5, p value&lt; 0.05. All probes: <italic>Mus musculus</italic>.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0160034.s004.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0160034.s005">
                <label>S4 Table</label>
                <caption>
                  <title>Complete list of trabecular osteoblast genes whose expression is modified by intermittent PTHrP<sub>1-36</sub> treatment (total 163 genes).</title>
                  <p><bold>(A)</bold> Genes (total 102) upregulated by intermittent PTHrP<sub>1-36</sub> treatment. Fold change &gt; 1.5, p &lt; 0.05. <bold>(B)</bold> Genes (total 61) downregulated by treatment. Fold changes &lt; 0.66, p &lt; 0.05.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0160034.s005.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>This work was completed through the Canadian Space Agency (CSA) E/Osteo program contract # 9F-007-05-1657 and a grant to Dr. David Goltzman from the Canadian Institutes of Health Research (FRN-86703). We thank Dr Perry Johnson-Green (Senior Program Scientist, Life Sciences, Space Exploration, Canadian Space Agency) and Dr Nicole Buckley (Chief Scientist, Life Sciences and the International Space Station, Canadian Space Agency) for scientific help throughout the project, Engineers Bastien Dufour (Mission Manager) Luc Lefebvre (Head, International Space Station Projects and Payloads Development, Canadian Space Agency) Lowell Misener and Margaret Eberle (CALM Technologies) for excellent technical supervision, and Dr Richard Kremer (Department of Endocrinology, Faculty of Medicine, McGill University) for helpful scientific discussion.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0160034.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Goltzman</surname><given-names>D</given-names></name>. <article-title>Discoveries, drugs and skeletal disorders</article-title>. <source>Nat Rev Drug Discov</source>. <year>2002</year>;<volume>1</volume>(<issue>10</issue>):<fpage>784</fpage>–<lpage>96</lpage>. <?supplied-pmid 12360256?><pub-id pub-id-type="pmid">12360256</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Nagaraja</surname><given-names>MP</given-names></name>, <name><surname>Risin</surname><given-names>D</given-names></name>. <article-title>The current state of bone loss research: data from spaceflight and microgravity simulators</article-title>. <source>Journal of cellular biochemistry</source>. <year>2013</year>;<volume>114</volume>(<issue>5</issue>):<fpage>1001</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.24454</pub-id>
<?supplied-pmid 23150462?><pub-id pub-id-type="pmid">23150462</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Carmeliet</surname><given-names>G</given-names></name>, <name><surname>Vico</surname><given-names>L</given-names></name>, <name><surname>Bouillon</surname><given-names>R</given-names></name>. <article-title>Space flight: a challenge for notmal bone homeostasis</article-title>. <source>Critical Reviews in Eukaryotic Gene Expression</source>. <year>2001</year>;<volume>11</volume>(<issue>1–3</issue>):<fpage>131</fpage>–<lpage>44</lpage>. <?supplied-pmid 11693958?><pub-id pub-id-type="pmid">11693958</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Payne</surname><given-names>MWC</given-names></name>, <name><surname>Williams</surname><given-names>DR</given-names></name>, <name><surname>Trudel</surname><given-names>G</given-names></name>. <article-title>Space flight rehabilitation</article-title>. <source>American journal of physical medicine &amp; rehabilitation</source>. <year>2007</year>;<volume>86</volume>(<issue>7</issue>):<fpage>583</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">17167347</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Vernikos</surname><given-names>J</given-names></name>, <name><surname>Schneider</surname><given-names>VS</given-names></name>. <article-title>Space, gravity and the physiology of aging: parallel or convergent disciplines? A mini-review</article-title>. <source>Gerontology</source>. <year>2010</year>;<volume>56</volume>(<issue>2</issue>):<fpage>157</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1159/000252852</pub-id>
<?supplied-pmid 19851058?><pub-id pub-id-type="pmid">19851058</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Cavanagh</surname><given-names>PR</given-names></name>, <name><surname>Licata</surname><given-names>AA</given-names></name>, <name><surname>Rice</surname><given-names>AJ</given-names></name>. <article-title>Exercise and pharmacological countermeasures for bone loss during long-duration space flight</article-title>. <source>Gravitational and Space Biology</source>. <year>2005</year>;<volume>18</volume>:<fpage>39</fpage>–<lpage>58</lpage>. <?supplied-pmid 16038092?><pub-id pub-id-type="pmid">16038092</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref007">
                <label>7</label>
                <mixed-citation publication-type="other">LeBlanc A, Schneider V, Shackelford L, West S, Oganov V, Bakulin A, et al. Bone mineral and lean tissue loss after long duration spaceflight. Journal of Bone and Mineral Research; American Society of Bone and Mineral Research 18th Annual Meeting1996. p. S323.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>LeBlanc</surname><given-names>A</given-names></name>, <name><surname>Shackelford</surname><given-names>L</given-names></name>, <name><surname>Schneider</surname><given-names>V</given-names></name>. <article-title>Future Human Bone Research in Space</article-title>. <source>Bone</source>. <year>1998</year>;<volume>22</volume>(<issue>5, Supplement 1</issue>):<fpage>113S</fpage>–<lpage>6S</lpage>.<pub-id pub-id-type="pmid">9600765</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Shackelford</surname><given-names>LC</given-names></name>, <name><surname>LeBlanc</surname><given-names>AD</given-names></name>, <name><surname>Driscoll</surname><given-names>TB</given-names></name>, <name><surname>Evans</surname><given-names>HJ</given-names></name>, <name><surname>Rianon</surname><given-names>NJ</given-names></name>, <name><surname>Smith</surname><given-names>SM</given-names></name>, <etal>et al</etal><article-title>Resistance exercise as a countermeasure to disuse-induced bone loss</article-title>. <source>Journal of Applied Physiology</source>. <year>2004</year>;<volume>97</volume>(<issue>1</issue>):<fpage>119</fpage>–<lpage>29</lpage>. <?supplied-pmid 15220316?><pub-id pub-id-type="pmid">15220316</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Vico</surname><given-names>L</given-names></name>, <name><surname>Collet</surname><given-names>P</given-names></name>, <name><surname>Guignandon</surname><given-names>A</given-names></name>, <name><surname>Lafage-Proust</surname><given-names>M-Hln</given-names></name>, <name><surname>Thomas</surname><given-names>T</given-names></name>, <name><surname>Rehailia</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts</article-title>. <source>The Lancet</source>. <year>2000</year>;<volume>355</volume>(<issue>9215</issue>):<fpage>1607</fpage>–<lpage>11</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Kaderka</surname><given-names>J</given-names></name>, <name><surname>Young</surname><given-names>LR</given-names></name>, <name><surname>Paloski</surname><given-names>WH</given-names></name>. <article-title>A critical benefit analysis of artificial gravity as a microgravity countermeasure</article-title>. <source>Acta Astronautica</source>. <year>2010</year>;<volume>67</volume>(<issue>9–10</issue>):<fpage>1090</fpage>–<lpage>102</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Buckey</surname><given-names>J</given-names></name>. <article-title>Bone loss: managing calcium and bone loss in space</article-title>. <source>Space Physiology</source>. <year>2006</year>;<volume>5</volume>:<fpage>3</fpage>–<lpage>25</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Lang</surname><given-names>T</given-names></name>, <name><surname>LeBlanc</surname><given-names>A</given-names></name>, <name><surname>Evans</surname><given-names>H</given-names></name>, <name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Genant</surname><given-names>H</given-names></name>, <name><surname>Yu</surname><given-names>A</given-names></name>. <article-title>Cortical and Trabecular Bone Mineral Loss From the Spine and Hip in Long-Duration Spaceflight</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2004</year>;<volume>19</volume>(<issue>6</issue>):<fpage>1006</fpage>–<lpage>12</lpage>. <?supplied-pmid 15125798?><pub-id pub-id-type="pmid">15125798</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>LeBlanc</surname><given-names>A</given-names></name>, <name><surname>Schneider</surname><given-names>V</given-names></name>, <name><surname>Shackelford</surname><given-names>L</given-names></name>, <name><surname>West</surname><given-names>S</given-names></name>, <name><surname>Oganov</surname><given-names>V</given-names></name>, <name><surname>Bakulin</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Bone mineral and lean tissue loss after long duration space flight</article-title>. <source>Journal of Musculoskeletal and Neuronal Interactions</source>. <year>2000</year>;<volume>1</volume>(<issue>2</issue>):<fpage>157</fpage>–<lpage>60</lpage>. <?supplied-pmid 15758512?><pub-id pub-id-type="pmid">15758512</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Nabavi</surname><given-names>N</given-names></name>, <name><surname>Khandani</surname><given-names>A</given-names></name>, <name><surname>Camirand</surname><given-names>A</given-names></name>, <name><surname>Harrison</surname><given-names>RE</given-names></name>. <article-title>Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion</article-title>. <source>Bone</source>. <year>2011</year>;<volume>49</volume>(<issue>5</issue>):<fpage>965</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2011.07.036</pub-id>
<?supplied-pmid 21839189?><pub-id pub-id-type="pmid">21839189</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>ST</given-names></name>, <name><surname>MacDougall</surname><given-names>HG</given-names></name>. <article-title>Journey to Mars: Physiological Effects and Operational Consequences of Long-Duration Microgravity Exposure</article-title>. <source>Journal of Cosmology</source>. <year>2010</year>;<volume>12</volume>:<fpage>3781</fpage>–<lpage>93</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>LeBlanc</surname><given-names>A</given-names></name>, <name><surname>Driscoll</surname><given-names>TB</given-names></name>, <name><surname>Shackelford</surname><given-names>L</given-names></name>, <name><surname>Evans</surname><given-names>HJ</given-names></name>, <name><surname>Rianon</surname><given-names>NJ</given-names></name>, <name><surname>Smith</surname><given-names>SM</given-names></name>, <etal>et al</etal><article-title>Alendronate as an effective countermeasure to disuse induced bone loss</article-title>. <source>Journal of Musculoskeletal and Neuronal Interactions</source>. <year>2002</year>;<volume>2</volume>(<issue>4</issue>):<fpage>335</fpage>–<lpage>43</lpage>. <?supplied-pmid 15758425?><pub-id pub-id-type="pmid">15758425</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>Y</given-names></name>, <name><surname>Ohshima</surname><given-names>H</given-names></name>, <name><surname>Mizuno</surname><given-names>K</given-names></name>, <name><surname>Sekiguchi</surname><given-names>C</given-names></name>, <name><surname>Fukunaga</surname><given-names>M</given-names></name>, <name><surname>Kohri</surname><given-names>K</given-names></name>, <etal>et al</etal><article-title>Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90-Day Bed Rest</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2004</year>;<volume>19</volume>(<issue>11</issue>):<fpage>1771</fpage>–<lpage>8</lpage>. <?supplied-pmid 15476576?><pub-id pub-id-type="pmid">15476576</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Mashiba</surname><given-names>T</given-names></name>, <name><surname>Turner</surname><given-names>CH</given-names></name>, <name><surname>Hirano</surname><given-names>T</given-names></name>, <name><surname>Forwood</surname><given-names>MR</given-names></name>, <name><surname>Jacob</surname><given-names>DS</given-names></name>, <name><surname>Johnston</surname><given-names>CC</given-names></name>, <etal>et al</etal><article-title>Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures</article-title>. <source>Bone</source>. <year>2001</year>;<volume>29</volume>(<issue>3</issue>):<fpage>271</fpage>–<lpage>8</lpage>. <?supplied-pmid 11557372?><pub-id pub-id-type="pmid">11557372</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Lloyd</surname><given-names>SAJ</given-names></name>, <name><surname>Travis</surname><given-names>ND</given-names></name>, <name><surname>Lu</surname><given-names>T</given-names></name>, <name><surname>Bateman</surname><given-names>TA</given-names></name>. <article-title>Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse</article-title>. <source>Journal of Applied Physiology</source>. <year>2008</year>;<volume>104</volume>(<issue>3</issue>):<fpage>729</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00632.2007</pub-id>
<?supplied-pmid 18174391?><pub-id pub-id-type="pmid">18174391</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Esbrit</surname><given-names>P</given-names></name>, <name><surname>Alcaraz</surname><given-names>MJ</given-names></name>. <article-title>Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies</article-title>. <source>Biochemical pharmacology</source>. <year>2013</year>;<volume>85</volume>(<issue>10</issue>):<fpage>1417</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2013.03.002</pub-id>
<?supplied-pmid 23500550?><pub-id pub-id-type="pmid">23500550</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Esbrit</surname><given-names>P</given-names></name>, <name><surname>Herrera</surname><given-names>S</given-names></name>, <name><surname>Portal-Núñez</surname><given-names>S</given-names></name>, <name><surname>Nogués</surname><given-names>X</given-names></name>, <name><surname>Díez-Pérez</surname><given-names>A</given-names></name>. <article-title>Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies</article-title>. <source>Calcified tissue international</source>. <year>2015</year>:<fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>McCauley</surname><given-names>LK</given-names></name>, <name><surname>Martin</surname><given-names>TJ</given-names></name>. <article-title>Twenty-five years of PTHrP progress: From cancer hormone to multifunctional cytokine</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2012</year>;<volume>27</volume>(<issue>6</issue>):<fpage>1231</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.1617</pub-id>
<?supplied-pmid 22549910?><pub-id pub-id-type="pmid">22549910</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Wysolmerski</surname><given-names>JJ</given-names></name>. <article-title>Parathyroid Hormone-Related Protein: An Update</article-title>. <source>Journal of Clinical Endocrinology &amp; Metabolism</source>. <year>2012</year>;<volume>97</volume>(<issue>9</issue>):<fpage>2947</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">22745236</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Amizuka</surname><given-names>N</given-names></name>, <name><surname>Warshawsky</surname><given-names>H</given-names></name>, <name><surname>Henderson</surname><given-names>JE</given-names></name>, <name><surname>Goltzman</surname><given-names>D</given-names></name>, <name><surname>Karaplis</surname><given-names>AC</given-names></name>. <article-title>Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation</article-title>. <source>The Journal of Cell Biology</source>. <year>1994</year>;<volume>126</volume>(<issue>6</issue>):<fpage>1611</fpage><?supplied-pmid 8089190?><pub-id pub-id-type="pmid">8089190</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Karaplis</surname><given-names>AC</given-names></name>, <name><surname>Luz</surname><given-names>A</given-names></name>, <name><surname>Glowacki</surname><given-names>J</given-names></name>, <name><surname>Bronson</surname><given-names>RT</given-names></name>, <name><surname>Tybulewicz</surname><given-names>VL</given-names></name>, <name><surname>Kronenberg</surname><given-names>HM</given-names></name>, <etal>et al</etal><article-title>Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene</article-title>. <source>Genes &amp; Development</source>. <year>1994</year>;<volume>8</volume>(<issue>3</issue>):<fpage>277</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">8314082</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Miao</surname><given-names>D</given-names></name>, <name><surname>He</surname><given-names>B</given-names></name>, <name><surname>Karaplis</surname><given-names>AC</given-names></name>, <name><surname>Goltzman</surname><given-names>D</given-names></name>. <article-title>Parathyroid hormone is essential for normal fetal bone formation</article-title>. <source>Journal of Clinical Investigation</source>. <year>2002</year>;<volume>109</volume>(<issue>9</issue>):<fpage>1173</fpage>–<lpage>82</lpage>. <?supplied-pmid 11994406?><pub-id pub-id-type="pmid">11994406</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Amizuka</surname><given-names>N</given-names></name>, <name><surname>Karaplis</surname><given-names>AC</given-names></name>, <name><surname>Henderson</surname><given-names>JE</given-names></name>, <name><surname>Warshawsky</surname><given-names>H</given-names></name>, <name><surname>Lipman</surname><given-names>ML</given-names></name>, <name><surname>Matsuki</surname><given-names>Y</given-names></name>, <etal>et al</etal><article-title>Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development</article-title>. <source>Developmental biology</source>. <year>1996</year>;<volume>175</volume>(<issue>1</issue>):<fpage>166</fpage>–<lpage>76</lpage>. <?supplied-pmid 8608863?><pub-id pub-id-type="pmid">8608863</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Miao</surname><given-names>D</given-names></name>, <name><surname>He</surname><given-names>B</given-names></name>, <name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Kobayashi</surname><given-names>T</given-names></name>, <name><surname>Soroc</surname><given-names>xE</given-names></name>, <etal>et al</etal><article-title>Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34</article-title>. <source>The Journal of Clinical Investigation</source>. <year>2005</year>;<volume>115</volume>(<issue>9</issue>):<fpage>2402</fpage>–<lpage>11</lpage>. <?supplied-pmid 16138191?><pub-id pub-id-type="pmid">16138191</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Horwitz</surname><given-names>MJ</given-names></name>, <name><surname>Tedesco</surname><given-names>MB</given-names></name>, <name><surname>Garcia-Ocana</surname><given-names>A</given-names></name>, <name><surname>Sereika</surname><given-names>SM</given-names></name>, <name><surname>Prebehala</surname><given-names>L</given-names></name>, <name><surname>Bisello</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Parathyroid Hormone-Related Protein for the Treatment of Postmenopausal Osteoporosis: Defining the Maximal Tolerable Dose</article-title>. <source>Journal of Clinical Endocrinology &amp; Metabolism</source>. <year>2010</year>;<volume>95</volume>(<issue>3</issue>):<fpage>1279</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">20061412</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Hardwick</surname><given-names>T</given-names></name>, <name><surname>Kalia</surname><given-names>P</given-names></name>, <name><surname>Baawa-Ameyaw</surname><given-names>J</given-names></name>, <name><surname>Lozano</surname><given-names>D</given-names></name>, <name><surname>Sinha</surname><given-names>J</given-names></name>, <name><surname>Di Silvio</surname><given-names>L</given-names></name>. <article-title>Continued vs Intermittent Cell Exposure to Parathyroid Hormone-Related Peptide (1–36) on Osteogenic and Angiogenic Gene Expression in Human Osteoblasts and Bone Marrow Stromal Cells</article-title>. <source>Bone &amp; Joint Journal Orthopaedic Proceedings Supplement</source>. <year>2013</year>;<volume>95</volume>(<issue>SUPP 13</issue>):<fpage>24</fpage>-.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>De Gortázar</surname><given-names>A</given-names></name>, <name><surname>Alonso</surname><given-names>V</given-names></name>, <name><surname>Alvarez-Arroyo</surname><given-names>M</given-names></name>, <name><surname>Esbrit</surname><given-names>P</given-names></name>. <article-title>Transient exposure to PTHrP (107–139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro</article-title>. <source>Calcified tissue international</source>. <year>2006</year>;<volume>79</volume>(<issue>5</issue>):<fpage>360</fpage>–<lpage>9</lpage>. <?supplied-pmid 17120184?><pub-id pub-id-type="pmid">17120184</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Torday</surname><given-names>JS</given-names></name>. <article-title>Parathyroid hormone-related protein is a gravisensor in lung and bone cell biology</article-title>. <source>Advances in Space Research</source>. <year>2003</year>;<volume>32</volume>(<issue>8</issue>):<fpage>1569</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/S0273-1177(03)90397-8</pub-id>
<?supplied-pmid 15000128?><pub-id pub-id-type="pmid">15000128</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Maniatopoulos</surname><given-names>C</given-names></name>, <name><surname>Sodek</surname><given-names>J</given-names></name>, <name><surname>Melcher</surname><given-names>A</given-names></name>. <article-title>Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats</article-title>. <source>Cell and tissue research</source>. <year>1988</year>;<volume>254</volume>(<issue>2</issue>):<fpage>317</fpage>–<lpage>30</lpage>. <?supplied-pmid 3197089?><pub-id pub-id-type="pmid">3197089</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Zayzafoon</surname><given-names>M</given-names></name>, <name><surname>Gathings</surname><given-names>WE</given-names></name>, <name><surname>McDonald</surname><given-names>JM</given-names></name>. <article-title>Modeled Microgravity Inhibits Osteogenic Differentiation of Human Mesenchymal Stem Cells and Increases Adipogenesis</article-title>. <source>Endocrinology</source>. <year>2004</year>;<volume>145</volume>(<issue>5</issue>):<fpage>2421</fpage>–<lpage>32</lpage>. <?supplied-pmid 14749352?><pub-id pub-id-type="pmid">14749352</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Horwitz</surname><given-names>MJ</given-names></name>, <name><surname>Tedesco</surname><given-names>MB</given-names></name>, <name><surname>Sereika</surname><given-names>SM</given-names></name>, <name><surname>Syed</surname><given-names>MA</given-names></name>, <name><surname>Garcia-Ocana</surname><given-names>A</given-names></name>, <name><surname>Bisello</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1, 25 (OH) 2Vitamin D</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2005</year>;<volume>20</volume>(<issue>10</issue>):<fpage>1792</fpage>–<lpage>803</lpage>. <?supplied-pmid 16160737?><pub-id pub-id-type="pmid">16160737</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Blaise</surname><given-names>SA</given-names></name>, <name><surname>Nédélec</surname><given-names>E</given-names></name>, <name><surname>Schroeder</surname><given-names>H</given-names></name>, <name><surname>Alberto</surname><given-names>J-M</given-names></name>, <name><surname>Bossenmeyer-Pourié</surname><given-names>C</given-names></name>, <name><surname>Guéant</surname><given-names>J-L</given-names></name>, <etal>et al</etal><article-title>Gestational Vitamin B Deficiency Leads to Homocysteine-Associated Brain Apoptosis and Alters Neurobehavioral Development in Rats</article-title>. <source>The American Journal of Pathology</source>. <year>2007</year>;<volume>170</volume>(<issue>2</issue>):<fpage>667</fpage>–<lpage>79</lpage>. <?supplied-pmid 17255334?><pub-id pub-id-type="pmid">17255334</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Frisch</surname><given-names>S</given-names></name>, <name><surname>Francis</surname><given-names>H</given-names></name>. <article-title>Disruption of epithelial cell-matrix interactions induces apoptosis</article-title>. <source>The Journal of Cell Biology</source>. <year>1994</year>;<volume>124</volume>(<issue>4</issue>):<fpage>619</fpage>–<lpage>26</lpage>. <?supplied-pmid 8106557?><pub-id pub-id-type="pmid">8106557</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Ontiveros</surname><given-names>C</given-names></name>, <name><surname>McCabe</surname><given-names>LR</given-names></name>. <article-title>Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation</article-title>. <source>Journal of Cellular Biochemistry</source>. <year>2003</year>;<volume>88</volume>(<issue>3</issue>):<fpage>427</fpage>–<lpage>37</lpage>. <?supplied-pmid 12532319?><pub-id pub-id-type="pmid">12532319</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Sarkar</surname><given-names>D</given-names></name>, <name><surname>Nagaya</surname><given-names>T</given-names></name>, <name><surname>Koga</surname><given-names>K</given-names></name>, <name><surname>Nomura</surname><given-names>Y</given-names></name>, <name><surname>Gruener</surname><given-names>R</given-names></name>, <name><surname>Seo</surname><given-names>H</given-names></name>. <article-title>Culture in Vector-Averaged Gravity Under Clinostat Rotation Results in Apoptosis of Osteoblastic ROS 17/2.8 Cells</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2000</year>;<volume>15</volume>(<issue>3</issue>):<fpage>489</fpage>–<lpage>98</lpage>. <?supplied-pmid 10750563?><pub-id pub-id-type="pmid">10750563</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref041">
                <label>41</label>
                <mixed-citation publication-type="other">Blazejczyk M, Miron M, Nadon R. FlexArray: a statistical data analysis software for gene expression microarrays. Montréal, QC2007. Available from: <ext-link ext-link-type="uri" xlink:href="http://genomequebec.mcgill.ca/FlexArray">http://genomequebec.mcgill.ca/FlexArray</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>DW</given-names></name>, <name><surname>Sherman</surname><given-names>BT</given-names></name>, <name><surname>Lempicki</surname><given-names>RA</given-names></name>. <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat Protocols</source>. <year>2008</year>;<volume>4</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>57</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Pathan</surname><given-names>M</given-names></name>, <name><surname>Keerthikumar</surname><given-names>S</given-names></name>, <name><surname>Ang</surname><given-names>CS</given-names></name>, <name><surname>Gangoda</surname><given-names>L</given-names></name>, <name><surname>Quek</surname><given-names>CY</given-names></name>, <name><surname>Williamson</surname><given-names>NA</given-names></name>, <etal>et al</etal><article-title>Technical brief funrich: An open access standalone functional enrichment and interaction network analysis tool</article-title>. <source>Proteomics</source>. <year>2015</year>;<volume>15</volume>:<fpage>2597</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">25921073</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Unsworth</surname><given-names>BR</given-names></name>, <name><surname>Lelkes</surname><given-names>PI</given-names></name>. <article-title>Growing tissues in microgravity</article-title>. <source>Nature Medicine</source>. <year>1998</year>;<volume>4</volume>(<issue>8</issue>):<fpage>901</fpage>–<lpage>7</lpage>. <?supplied-pmid 9701241?><pub-id pub-id-type="pmid">9701241</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>LeBlanc</surname><given-names>A</given-names></name>, <name><surname>Spector</surname><given-names>E</given-names></name>, <name><surname>Evans</surname><given-names>H</given-names></name>, <name><surname>Sibonga</surname><given-names>J</given-names></name>. <article-title>Skeletal responses to space flight and the bed rest analog: a review</article-title>. <source>Journal of Musculoskeletal and Neuronal Interactions</source>. <year>2007</year>;<volume>7</volume>(<issue>1</issue>):<fpage>33</fpage><?supplied-pmid 17396004?><pub-id pub-id-type="pmid">17396004</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Robling</surname><given-names>AG</given-names></name>, <name><surname>Castillo</surname><given-names>AB</given-names></name>, <name><surname>Turner</surname><given-names>CH</given-names></name>. <article-title>Biomechanical and molecular regulation of bone remodeling</article-title>. <source>Annu Rev Biomed Eng</source>. <year>2006</year>;<volume>8</volume>:<fpage>455</fpage>–<lpage>98</lpage>. <?supplied-pmid 16834564?><pub-id pub-id-type="pmid">16834564</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Pardo</surname><given-names>SJ</given-names></name>, <name><surname>Patel</surname><given-names>MJ</given-names></name>, <name><surname>Sykes</surname><given-names>MC</given-names></name>, <name><surname>Platt</surname><given-names>MO</given-names></name>, <name><surname>Boyd</surname><given-names>NL</given-names></name>, <name><surname>Sorescu</surname><given-names>GP</given-names></name>, <etal>et al</etal><article-title>Simulated microgravity using the Random Positioning Machine inhibits differentiation and alters gene expression profiles of 2T3 preosteoblasts</article-title>. <source>American Journal of Physiology—Cell Physiology</source>. <year>2005</year>;<volume>288</volume>(<issue>6</issue>):<fpage>C1211</fpage>–<lpage>C21</lpage>. <?supplied-pmid 15689415?><pub-id pub-id-type="pmid">15689415</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>JA</given-names></name>, <name><surname>Chatterjee-Kishore</surname><given-names>M</given-names></name>, <name><surname>Yaworsky</surname><given-names>PJ</given-names></name>, <name><surname>Cullen</surname><given-names>DM</given-names></name>, <name><surname>Zhao</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <etal>et al</etal><article-title>Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone</article-title>. <source>Journal of Biological Chemistry</source>. <year>2006</year>;<volume>281</volume>(<issue>42</issue>):<fpage>31720</fpage>–<lpage>8</lpage>. <?supplied-pmid 16908522?><pub-id pub-id-type="pmid">16908522</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Rolfe</surname><given-names>RA</given-names></name>, <name><surname>Nowlan</surname><given-names>NC</given-names></name>, <name><surname>Kenny</surname><given-names>EM</given-names></name>, <name><surname>Cormican</surname><given-names>P</given-names></name>, <name><surname>Morris</surname><given-names>DW</given-names></name>, <name><surname>Prendergast</surname><given-names>PJ</given-names></name>, <etal>et al</etal><article-title>Identification of mechanosensitive genes during skeletal development: alteration of genes associated with cytoskeletal rearrangement and cell signalling pathways</article-title>. <source>BMC genomics</source>. <year>2014</year>;<volume>15</volume>(<issue>1</issue>):<fpage>1</fpage>.<pub-id pub-id-type="pmid">24382143</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Maycas</surname><given-names>M</given-names></name>, <name><surname>Ardura</surname><given-names>JA</given-names></name>, <name><surname>de Castro</surname><given-names>LF</given-names></name>, <name><surname>Bravo</surname><given-names>B</given-names></name>, <name><surname>Gortázar</surname><given-names>AR</given-names></name>, <name><surname>Esbrit</surname><given-names>P</given-names></name>. <article-title>Role of the parathyroid hormone type 1 receptor (PTH1R) as a mechanosensor in osteocyte survival</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2015</year>;<volume>30</volume>(<issue>7</issue>):<fpage>1231</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.2439</pub-id>
<?supplied-pmid 25529820?><pub-id pub-id-type="pmid">25529820</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Macica</surname><given-names>CM</given-names></name>, <name><surname>Ng</surname><given-names>KW</given-names></name>, <name><surname>Broadus</surname><given-names>AE</given-names></name>. <article-title>Stretch-Induced PTH-Related Protein Gene Expression in Osteoblasts</article-title>. <source>Journal of bone and mineral research</source>. <year>2005</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1454</fpage>–<lpage>61</lpage>. <?supplied-pmid 16007342?><pub-id pub-id-type="pmid">16007342</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Sowers</surname><given-names>M</given-names></name>. <article-title>Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>1996</year>;<volume>11</volume>(<issue>8</issue>):<fpage>1052</fpage>–<lpage>60</lpage>. <?supplied-pmid 8854240?><pub-id pub-id-type="pmid">8854240</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref053">
                <label>53</label>
                <mixed-citation publication-type="journal"><name><surname>VanHouten</surname><given-names>JN</given-names></name>, <name><surname>Wysolmerski</surname><given-names>JJ</given-names></name>. <article-title>Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice</article-title>. <source>Endocrinology</source>. <year>2003</year>;<volume>144</volume>(<issue>12</issue>):<fpage>5521</fpage>–<lpage>9</lpage>. <?supplied-pmid 14500568?><pub-id pub-id-type="pmid">14500568</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Coss</surname><given-names>D</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Kuo</surname><given-names>CB</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Luben</surname><given-names>RA</given-names></name>, <name><surname>Walker</surname><given-names>AM</given-names></name>. <article-title>Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat</article-title>. <source>American Journal of Physiology-Endocrinology And Metabolism</source>. <year>2000</year>;<volume>279</volume>(<issue>6</issue>):<fpage>E1216</fpage>–<lpage>E25</lpage>. <?supplied-pmid 11093907?><pub-id pub-id-type="pmid">11093907</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Greenspan</surname><given-names>SL</given-names></name>, <name><surname>Neer</surname><given-names>RM</given-names></name>, <name><surname>Ridgway</surname><given-names>EC</given-names></name>, <name><surname>Klibanski</surname><given-names>A</given-names></name>. <article-title>Osteoporosis in men with hyperprolactinemic hypogonadism</article-title>. <source>Annals of internal medicine</source>. <year>1986</year>;<volume>104</volume>(<issue>6</issue>):<fpage>777</fpage>–<lpage>82</lpage>. <?supplied-pmid 3706929?><pub-id pub-id-type="pmid">3706929</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>O’sullivan</surname><given-names>S</given-names></name>, <name><surname>Grey</surname><given-names>A</given-names></name>, <name><surname>Singh</surname><given-names>R</given-names></name>, <name><surname>Reid</surname><given-names>I</given-names></name>. <article-title>Bisphosphonates in pregnancy and lactation-associated osteoporosis</article-title>. <source>Osteoporosis international</source>. <year>2006</year>;<volume>17</volume>(<issue>7</issue>):<fpage>1008</fpage>–<lpage>12</lpage>. <?supplied-pmid 16758139?><pub-id pub-id-type="pmid">16758139</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>O'Keane</surname><given-names>V</given-names></name>, <name><surname>Meaney</surname><given-names>AM</given-names></name>. <article-title>Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?</article-title><source>Journal of clinical psychopharmacology</source>. <year>2005</year>;<volume>25</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>31</lpage>. <?supplied-pmid 15643097?><pub-id pub-id-type="pmid">15643097</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Macho</surname><given-names>L</given-names></name>, <name><surname>Jezova</surname><given-names>D</given-names></name>, <name><surname>Jurcovicova</surname><given-names>J</given-names></name>, <name><surname>Kvetnanský</surname><given-names>R</given-names></name>, <name><surname>Vigas</surname><given-names>M</given-names></name>, <name><surname>Serova</surname><given-names>L</given-names></name>. <article-title>Effect of space flight on the development of endocrine functions in rats</article-title>. <source>Endocrine regulations</source>. <year>1993</year>;<volume>27</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>22</lpage>. <?supplied-pmid 8003702?><pub-id pub-id-type="pmid">8003702</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Cagnati</surname><given-names>P</given-names></name>, <name><surname>Puppo</surname><given-names>F</given-names></name>. <article-title>Multiparametricendocrine evaluation of healthy subjects undergoing prolonged head down tilt bed rest anti-gravitary posture</article-title>. <source>Stress</source>. <year>2013</year>;<volume>1</volume>:<fpage>3</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0160034.ref060">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Kita</surname><given-names>H</given-names></name>, <name><surname>Carmichael</surname><given-names>J</given-names></name>, <name><surname>Swartz</surname><given-names>J</given-names></name>, <name><surname>Muro</surname><given-names>S</given-names></name>, <name><surname>Wyttenbach</surname><given-names>A</given-names></name>, <name><surname>Matsubara</surname><given-names>K</given-names></name>, <etal>et al</etal><article-title>Modulation of polyglutamine-induced cell death by genes identified by expression profiling</article-title>. <source>Human Molecular Genetics</source>. <year>2002</year>;<volume>11</volume>(<issue>19</issue>):<fpage>2279</fpage>–<lpage>87</lpage>. <?supplied-pmid 12217956?><pub-id pub-id-type="pmid">12217956</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Sutherland</surname><given-names>LC</given-names></name>, <name><surname>Rintala-Maki</surname><given-names>ND</given-names></name>, <name><surname>White</surname><given-names>RD</given-names></name>, <name><surname>Morin</surname><given-names>CD</given-names></name>. <article-title>RNA binding motif (RBM) proteins: A novel family of apoptosis modulators?</article-title><source>Journal of Cellular Biochemistry</source>. <year>2005</year>;<volume>94</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>24</lpage>. <?supplied-pmid 15514923?><pub-id pub-id-type="pmid">15514923</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref062">
                <label>62</label>
                <mixed-citation publication-type="journal"><name><surname>Tare</surname><given-names>RS</given-names></name>, <name><surname>Oreffo</surname><given-names>ROC</given-names></name>, <name><surname>Clarke</surname><given-names>NMP</given-names></name>, <name><surname>Roach</surname><given-names>HI</given-names></name>. <article-title>Pleiotrophin/Osteoblast-Stimulating Factor 1: Dissecting Its Diverse Functions in Bone Formation</article-title>. <source>Journal of Bone and Mineral Research</source>. <year>2002</year>;<volume>17</volume>(<issue>11</issue>):<fpage>2009</fpage>–<lpage>20</lpage>. <?supplied-pmid 12412809?><pub-id pub-id-type="pmid">12412809</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Rucci</surname><given-names>N</given-names></name>, <name><surname>Rufo</surname><given-names>A</given-names></name>, <name><surname>Alamanou</surname><given-names>M</given-names></name>, <name><surname>Teti</surname><given-names>A</given-names></name>. <article-title>Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio</article-title>. <source>Journal of Cellular Biochemistry</source>. <year>2007</year>;<volume>100</volume>(<issue>2</issue>):<fpage>464</fpage>–<lpage>73</lpage>. <?supplied-pmid 16927271?><pub-id pub-id-type="pmid">16927271</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref064">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>Suzuki</surname><given-names>H</given-names></name>, <name><surname>Nezaki</surname><given-names>Y</given-names></name>, <name><surname>Kuno</surname><given-names>E</given-names></name>, <name><surname>Sugiyama</surname><given-names>I</given-names></name>, <name><surname>Mizutani</surname><given-names>A</given-names></name>, <name><surname>Tsukagoshi</surname><given-names>N</given-names></name>. <article-title>Functional roles of the tissue inhibitor of metalloproteinase 3 (TIMP-3) during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells</article-title>. <source>Bioscience, biotechnology, and biochemistry</source>. <year>2003</year>;<volume>67</volume>(<issue>8</issue>):<fpage>1737</fpage>–<lpage>43</lpage>. <?supplied-pmid 12951508?><pub-id pub-id-type="pmid">12951508</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref065">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Gazzerro</surname><given-names>E</given-names></name>, <name><surname>Pereira</surname><given-names>RC</given-names></name>, <name><surname>Jorgetti</surname><given-names>V</given-names></name>, <name><surname>Olson</surname><given-names>S</given-names></name>, <name><surname>Economides</surname><given-names>AN</given-names></name>, <name><surname>Canalis</surname><given-names>E</given-names></name>. <article-title>Skeletal Overexpression of Gremlin Impairs Bone Formation and Causes Osteopenia</article-title>. <source>Endocrinology</source>. <year>2005</year>;<volume>146</volume>(<issue>2</issue>):<fpage>655</fpage>–<lpage>65</lpage>. <?supplied-pmid 15539560?><pub-id pub-id-type="pmid">15539560</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref066">
                <label>66</label>
                <mixed-citation publication-type="journal"><name><surname>Gazzerro</surname><given-names>E</given-names></name>, <name><surname>Smerdel-Ramoya</surname><given-names>A</given-names></name>, <name><surname>Zanotti</surname><given-names>S</given-names></name>, <name><surname>Stadmeyer</surname><given-names>L</given-names></name>, <name><surname>Durant</surname><given-names>D</given-names></name>, <name><surname>Economides</surname><given-names>AN</given-names></name>, <etal>et al</etal><article-title>Conditional Deletion of Gremlin Causes a Transient Increase in Bone Formation and Bone Mass</article-title>. <source>Journal of Biological Chemistry</source>. <year>2007</year>;<volume>282</volume>(<issue>43</issue>):<fpage>31549</fpage>–<lpage>57</lpage>. <?supplied-pmid 17785465?><pub-id pub-id-type="pmid">17785465</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref067">
                <label>67</label>
                <mixed-citation publication-type="journal"><name><surname>Martel-Pelletier</surname><given-names>J</given-names></name>, <name><surname>Di Battista</surname><given-names>JA</given-names></name>, <name><surname>Lajeunesse</surname><given-names>D</given-names></name>, <name><surname>Pelletier</surname><given-names>JP</given-names></name>. <article-title>IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis</article-title>. <source>Inflammation Research</source>. <year>1998</year>;<volume>47</volume>(<issue>3</issue>):<fpage>90</fpage>–<lpage>100</lpage>. <?supplied-pmid 9562333?><pub-id pub-id-type="pmid">9562333</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref068">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Nannuru</surname><given-names>K</given-names></name>, <name><surname>Singh</surname><given-names>R</given-names></name>. <article-title>Tumor-Stromal Interactions in Bone Metastasis</article-title>. <source>Current Osteoporosis Reports</source>. <year>2010</year>;<volume>8</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1007/s11914-010-0011-6</pub-id>
<?supplied-pmid 20425618?><pub-id pub-id-type="pmid">20425618</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref069">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Amaar</surname><given-names>YG</given-names></name>, <name><surname>Thompson</surname><given-names>GR</given-names></name>, <name><surname>Linkhart</surname><given-names>TA</given-names></name>, <name><surname>Chen</surname><given-names>S-T</given-names></name>, <name><surname>Baylink</surname><given-names>DJ</given-names></name>, <name><surname>Mohan</surname><given-names>S</given-names></name>. <article-title>Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2)</article-title>. <source>Journal of Biological Chemistry</source>. <year>2002</year>;<volume>277</volume>(<issue>14</issue>):<fpage>12053</fpage>–<lpage>60</lpage>. <?supplied-pmid 11821401?><pub-id pub-id-type="pmid">11821401</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref070">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Mishima</surname><given-names>S</given-names></name>, <name><surname>Nagai</surname><given-names>A</given-names></name>, <name><surname>Abdullah</surname><given-names>S</given-names></name>, <name><surname>Matsuda</surname><given-names>C</given-names></name>, <name><surname>Taketani</surname><given-names>T</given-names></name>, <name><surname>Kumakura</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent</article-title>. <source>European Journal of Haematology</source>. <year>2010</year>;<volume>84</volume>(<issue>6</issue>):<fpage>538</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0609.2010.01419.x</pub-id>
<?supplied-pmid 20088916?><pub-id pub-id-type="pmid">20088916</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Sibonga</surname><given-names>J</given-names></name>, <name><surname>Evans</surname><given-names>H</given-names></name>, <name><surname>Sung</surname><given-names>H</given-names></name>, <name><surname>Spector</surname><given-names>E</given-names></name>, <name><surname>Lang</surname><given-names>T</given-names></name>, <name><surname>Oganov</surname><given-names>V</given-names></name>, <etal>et al</etal><article-title>Recovery of spaceflight-induced bone loss: bone mineral density after long-duration missions as fitted with an exponential function</article-title>. <source>Bone</source>. <year>2007</year>;<volume>41</volume>(<issue>6</issue>):<fpage>973</fpage>–<lpage>8</lpage>. <?supplied-pmid 17931994?><pub-id pub-id-type="pmid">17931994</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Tilton</surname><given-names>FE</given-names></name>, <name><surname>Degioanni</surname><given-names>J</given-names></name>, <name><surname>Schneider</surname><given-names>V</given-names></name>. <article-title>Long-term follow-up of Skylab bone demineralization</article-title>. <source>Aviation, space, and environmental medicine</source>. <year>1980</year>;<volume>51</volume>(<issue>11</issue>):<fpage>1209</fpage><?supplied-pmid 7213266?><pub-id pub-id-type="pmid">7213266</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Estrada</surname><given-names>K</given-names></name>, <name><surname>Styrkarsdottir</surname><given-names>U</given-names></name>, <name><surname>Evangelou</surname><given-names>E</given-names></name>, <name><surname>Hsu</surname><given-names>Y-H</given-names></name>, <name><surname>Duncan</surname><given-names>EL</given-names></name>, <name><surname>Ntzani</surname><given-names>EE</given-names></name>, <etal>et al</etal><article-title>Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture</article-title>. <source>Nature genetics</source>. <year>2012</year>;<volume>44</volume>(<issue>5</issue>):<fpage>491</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2249</pub-id>
<?supplied-pmid 22504420?><pub-id pub-id-type="pmid">22504420</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref074">
                <label>74</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y-J</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Papasian</surname><given-names>CJ</given-names></name>, <name><surname>Deng</surname><given-names>H-W</given-names></name>. <article-title>Genome-wide association studies for osteoporosis: a 2013 update</article-title>. <source>Journal of bone metabolism</source>. <year>2014</year>;<volume>21</volume>(<issue>2</issue>):<fpage>99</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.11005/jbm.2014.21.2.99</pub-id>
<?supplied-pmid 25006567?><pub-id pub-id-type="pmid">25006567</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref075">
                <label>75</label>
                <mixed-citation publication-type="journal"><name><surname>Benisch</surname><given-names>P</given-names></name>, <name><surname>Schilling</surname><given-names>T</given-names></name>, <name><surname>Klein-Hitpass</surname><given-names>L</given-names></name>, <name><surname>Frey</surname><given-names>SP</given-names></name>, <name><surname>Seefried</surname><given-names>L</given-names></name>, <name><surname>Raaijmakers</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors</article-title>. <source>PLoS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>9</issue>):<fpage>e45142</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0045142</pub-id><?supplied-pmid 23028809?><pub-id pub-id-type="pmid">23028809</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0160034.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Trost</surname><given-names>Z</given-names></name>, <name><surname>Trebse</surname><given-names>R</given-names></name>, <name><surname>Prezelj</surname><given-names>J</given-names></name>, <name><surname>Komadina</surname><given-names>R</given-names></name>, <name><surname>Logar</surname><given-names>DB</given-names></name>, <name><surname>Marc</surname><given-names>J</given-names></name>. <article-title>A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts</article-title>. <source>Bone</source>. <year>2010</year>;<volume>46</volume>(<issue>1</issue>):<fpage>72</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2009.09.015</pub-id>
<?supplied-pmid 19781675?><pub-id pub-id-type="pmid">19781675</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
